Anthranilamides in combination with fungicides

ABSTRACT

The present invention relates to novel active compound combinations which include of the insecticidally active compounds of the formula (I) in combination with fungicidally active compounds (II) and are highly suitable for controlling unwanted animal pests, such as insects, and unwanted phytopathogenic fungi.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a Continuation of pending U.S. application Ser. No.13/177,752 filed Jul. 7, 2011, which claims priority to U.S. ProvisionalApplication No. 61/361,991 filed Jul. 7, 2010, the contents of which areincorporated by reference in their entireties.

FIELD OF INVENTION

The present invention relates to novel active compound combinationswhich consist of the insecticidally active compounds of the formula (I)in combination with fungicidally active compounds (II) and are highlysuitable for controlling unwanted animal pests, such as insects, acariand/or nematodes, and unwanted phytopathogenic fungi.

DESCRIPTION OF RELATED ART

Some of the anthranilamides of the formula (I) are already known from WO2007/144100, and their insecticidal action has been described. Theactive compounds referred to in this description by their common nameare known, for example, from “The Pesticide Manual” 14th Ed., BritishCrop Protection Council 2006, and the websitehttp://www.alanwood.net/pesticides.

However, the insecticidal and/or fungicidal activity and/or the activityspectrum and/or the plant compatibility of the known compounds,especially with respect to crop plants, is not always adequate.

SUMMARY OF THE INVENTION

It has now been found that active compound combinations comprising thecompounds of the general formula (I)

in which

-   R¹ represents hydrogen, amino, hydroxyl or represents C₁-C₆-alkyl,    C₂-C₆-alkenyl, C₂-C₆-alkynyl or C₃-C₆-cycloalkyl, each of which is    optionally mono- or polysubstituted by identical or different    substituents, where the substituents independently another may be    selected from the group consisting of halogen, cyano, nitro,    hydroxyl, C₁-C₄-alkoxy, C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl,    C₁-C₄-alkylsulphonyl, (C₁-C₄-alkoxy)carbonyl, C₁-C₄-alkylamino,    di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino and    (C₁-C₄-alkyl)-C₃-C₆-cycloalkylamino,-   R² represents hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,    C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄ alkylamino,    di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino, C₁-C₆-alkoxycarbonyl    or C₁-C₆-alkylcarbonyl,-   R³ represents hydrogen or represents C₁-C₆-alkyl, C₁-C₆-alkoxy,    C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₁₂-cycloalkyl,    C₃-C₁₂-cycloalkyl-C₁-C₆-alkyl, each of which is optionally mono- or    polysubstituted by identical or different substituents, where the    substituents independently of one another may be selected from the    group consisting of amino, C₃-C₆-cycloalkylamino, halogen, cyano,    carboxyl, carbamoyl, nitro, hydroxyl, C₁-C₆-alkyl, C₁-C₆-haloalkyl,    C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₆-alkoxycarbonyl,    C₁-C₆-alkylcarbonyl, C₃-C₆-trialkylsilyl and a saturated or    partially saturated heterocyclic ring, an aromatic or heteroaromatic    ring or a saturated, partially saturated or aromatic heterobicyclic    ring, where the ring or the ring system is optionally mono- or    polysubstituted by identical or different substituents from the    group consisting of SF₅, halogen, cyano, nitro, hydroxyl, amino,    carboxyl, carbamoyl, aminosulphonyl, C₁-C₆-alkyl, C₃-C₆-cycloalkyl,    C₁-C₄-alkoxy, C₁-C₆-haloalkyl, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-alkylsulphimino,    C₁-C₄-alkylsulphimino-C₁-C₄-alkyl,    C₁-C₄-alkylsulphimino-C₂-C₅-alkylcarbonyl, C₁-C₄-alkylsulphoximino,    C₁-C₄-alkylsulphoximino-C₁-C₄-alkyl,    C₁-C₄-alkylsulphoximino-C₂-C₅-alkylcarbonyl, C₁-C₆-alkoxycarbonyl,    C₁-C₆-alkylcarbonyl, C₃-C₆-trialkylsilyl, benzyl C₂-C₆-alkenyl,    C₂-C₆-alkynyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,    C₃-C₆-halocycloalkyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,    C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,    C₃-C₆-cycloalkylamino and a 3- to 6-membered ring, where the ring    may optionally be substituted by C₁-C₆-alkyl, halogen, cyano, nitro,    halo-(C₁-C₆)-alkyl, C₁-C₆-alkoxy or halo-(C₁-C₆)-alkoxy, or-   R³ represents C₁-C₆-alkoxycarbonyl, C₁-C₆-alkylcarbonyl,    C₁-C₆-alkylaminocarbonyl or di-(C₁-C₆)-alkylaminocarbonyl, or-   R³ furthermore represents a 5- or 6-membered aromatic or    heteroaromatic ring, a 4-, 5- or 6-membered partially saturated ring    or saturated heterocyclic ring, or a saturated, partially saturated    or aromatic heterobicyclic ring which may optionally contain one to    three heteroatoms from the group consisting of O, S and N, which    rings are mono- or polysubstituted by identical or different    substituents, where the substituents independently of one another    are selected from the group consisting of SF₅, halogen, cyano,    nitro, hydroxyl, amino, carboxyl, carbamoyl, C₁-C₆-alkyl,    C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₆-haloalkyl, C₁-C₄-haloalkoxy,    C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,    C₁-C₄-alkysulphimino, C₁-C₄-alkylsulphimino-C₁-C₄-alkyl,    C₁-C₄-alkylsulphimino-C₁-C₅-alkylcarbonyl C₁-C₄-alkylsulphoximino,    C₁-C₄-alkylsulphoximino-C₁-C₄-alkyl,    C₁-C₄-alkylsulphoximino-C₂-C₅-alkylcarbonyl, C₁-C₆-alkoxycarbonyl,    C₁-C₆-alkylcarbonyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,    C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl,    C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,    C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino    and C₃-C₆-cycloalkylamino, or a 3- to 6-membered ring, where the    ring may optionally be substituted by C₁-C₆-alkyl, halogen, cyano,    nitro, halo-(C₁-C₆)-alkyl, C₁-C₆-alkoxy or halo-(C₁-C₆)-alkoxy,-   R² and R³ may be linked with each other via two to six carbon atoms    and form a ring which optionally additionally contains a further    nitrogen, sulphur or oxygen atom and which may optionally be mono-    to tetrasubstituted by C₁-C₂-alkyl, C₁-C₂-haloalkyl, halogen, cyano,    amino, C₁-C₂-alkoxy or C₁-C₂-haloalkoxy,-   R², R³ furthermore together represent ═S(C₁-C₄-alkyl)₂ or    ═S(O)(C₁-C₄-alkyl)₂,-   R⁴ represents hydrogen, halogen, cyano, nitro C₁-C₄-alkyl,    C₁-C₄-haloalkyl, C₂-C₆-alkenyl, C₂-C₆-haloalkenyl, C₂-C₆-alkynyl,    C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, SF₅, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio,    C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl,    C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino,    (C₁-C₄-alkoxy)imino, (C₁-C₄-alkyl)(C₁-C₄-alkoxy)imino,    (C₁-C₄-haloalkyl)(C₁-C₄-alkoxy)imino or C₃-C₆-trialkylsilyl, or-   two R⁴, via adjacent carbon atoms, form a ring which represents    —(CH₂)₃—, —(CH₂)₄—, —(CH₂)₅—, —(CH═CH—)₂—, —OCH₂O—, —O(CH₂)₂O—,    —OCF₂O—, —(CF₂)₂O—, —O(CF₂)₂O—, —(CH═CH—CH═N)— or —(CH═CH—N═CH)—,-   two R⁴ furthermore, via adjacent carbon atoms, form the fused rings    below, which are optionally mono- or polysubstituted by identical or    different substituents, where the substituents independently of one    another may be selected from the group consisting of hydrogen,    C₁-C₆-alkyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl,    C₃-C₆-halocycloalkyl, halogen, C₁-C₆-alkoxy,    C₁-C₄-alkylthio-(C₁-C₆-alkyl), C₁-C₄-alkysulphinyl-(C₁-C₆-alkyl),    C₁-C₄-alkylsulphonyl-(C₁-C₆-alkyl), C₁-C₄-alkylamino,    di-(C₁-C₄-alkyl)amino and C₃-C₆-cycloalkylamino,

-   n represents 0 to 3,-   R⁵ represents C₁-C₆-alkyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl,    C₁C₆-halocycloalkyl, C₂C₆-alkenyl, C₂-C₆-haloalkenyl, C₂-C₆-alkynyl,    C₂-C₆-haloalkynyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,    C₂-C₄-haloalkylthio,C₁-C₄-haloalkylsulphinyl,    C₁-C₄-haloalkylsulphonyl, halogen, cyano, nitro or    C₃-C₆-trialkylsilyl,-   Q_(X) represents an aromatic or heteroaromatic 5- or 6-membered ring    which is optionally mono- or polysubstituted by identical or    different R⁷ substituents and Which may contain 1-3 heteroatoms from    the group consisting of N, S and O,-   A represents optionally mono- or polysubstituted —(C₁-C₆-alkylene)-,    —(C₂-C₆-alkenylene)-, —(C₂-C₆-alkynylene)-,    —R⁸—(C₃-C₆-cycloalkyl)-R⁸—, —R⁸—O—R⁸—, —R⁸—S—R⁸—, —R⁸—S(═O)—R⁸—,    —R⁸—S(═O)₂—R⁸—, —R⁸—N(C₁-C₆-alkyl)-R⁸—, —R⁸—C═NO(C₁-C₆-alkyl)-R⁸,    —CH[CO₂(C₁-C₆-alkyl)-, —R⁸—C(═O)—R⁸, —R⁸—C(═O)NH—R⁸,    R⁸—C(═O)N(C₁-C₆-alkyl)-R⁸, —R⁸—C(═O)NHNH—R⁸—,    —R⁸—C(═O)N(C₁-C₆-alkyl)-NH—R⁸—, —R⁸—C(═O)NHN(C₁-C₆-alkyl)-R⁸,    —R⁸—O(C═O)—R⁸, —R⁸—O(C═O)NH—R⁸, —R⁸—O(C═O)N(C₁-C₆-alkyl)-R⁸,    —R⁸—S(═O)₂NH—R⁸, —R⁸—S(═O)₂N(C₁-C₆-alkyl)-R⁸, —R⁸—S(C═O)—R⁸,    —R⁸—S(C═O)NH—R⁸, —R⁸—S(C═O)N(C₁-C₆-alkyl)-R⁸, —R⁸—NHNH—R⁸,    —R⁸—NHN(C₁-C₆-alkyl)-R⁸, —R⁸—N(C₁-C₆-alkyl)-NH—R⁸,    —R⁸—N(C₁-C₆-alkyl)-N(C₁-C₆-alkyl)-R⁸, —R⁸—N═CH—O—R⁸,    —R⁸—NH(C═O)O—R⁸, —R⁸—N(C₁-C₆-alkyl)-(C═O)O—R⁸, —R⁸—NH(C═O)NH—R⁸,    —R⁸—NH(C═S)NH—R⁸, —R⁸—NHS(═O)₂—R⁸, R⁸—NH—R⁸, R⁸—C(═O)—C(═O)—R⁸,    R⁸—C(OH)—R⁸, R⁸—NH(C═O)—R⁸, R⁸-Qz-R⁸, R⁸—C(═N—NR′₂)—R⁸,    R⁸—C(═C—R′₂)—R⁸ or —R⁸—N(C₁-C₆-alkyl)S(═O)₂—R⁸,-   where the substituents independently of one another may be selected    from the group consisting of halogen, cyano, nitro, hydroxyl,    C₁-C₆-alkyl, C₁-C₆-alkyloxy, halo-C₁-C₆-alkyl, amino,    (C₁-C₆-alkyl)amino, di-(C₁-C₆-alkyl)amino and C₃-C₆-cycloalkyl-   where —(C₃-C₆-cycloalkyl)- in the ring may optionally contain 1 or 2    heteroatoms selected from the group consisting of N, S and O,-   R⁸ represents straight-chain or branched —(C₁-C₆-alkylene)- or    represents a direct bond,-   where a plurality of R⁸ independently of one another represent    straight-chain or branched —(C₁-C₆-alkylene)- or represent a direct    bond,-   for example, R⁸—O—R⁸— represents    —(C₁-C₆alkylene)-O—(C₁-C₆-alkylene)-, —C₁-C₆-alkylene)-O—,    —O—(C₁-C₆-alkylene)-, or —O—,-   where R′ represents alkyl, alkylcarbonyl, alkenyl, alkynyl, which    may optionally be mono- or polysubstituted by halogen,-   Q_(Z) represents a 3- or 4-membered partially saturated or saturated    or a 5- or 6-membered partially saturated, saturated or aromatic    ring or represents a 6- to 10-membered bicyclic ring system,-   where the ring or the bicyclic ring system may optionally contain    1-3 heteroatoms from the group consisting of N, S and O,-   where the ring or the bicyclic ring system is optionally mono- or    polysubstituted by identical or different substituents and where the    substituents independently of one another may be selected from the    group consisting of hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl,    C₂-C₆-alkynyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, carbamoyl,    nitro, hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio,    C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl,    C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino,    (C₁-C₆-alkyl)carbonyl, (C₁-C₆-alkoxy)carbonyl,    (C₁-C₆-alkyl)aminocarbonyl and di-(C₁-C₄-alkyl)aminocarbonyl,-   Q_(Y) represents a 5- or 6-membered partially saturated or saturated    heterocyclic or heteroaromatic ring or an aromatic 8-, 9- or    10-membered fused heterobicyclic ring system, where the ring or the    ring system is optionally mono- or polysubstituted by identical or    different substituents and the substituents independently of one    another may be selected from the group consisting of hydrogen,    C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,    C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,    C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl, carbamoyl, nitro,    hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio,    C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl,    C₁-C₄-alkylamino, di-(C₁-C₆-alkyl)amino, C₃-C₆-cycloalkylamino,    (C₁-C₆-alkyl)carbonyl, (C₁-C₆-alkoxy)carbonyl,    (C₁-C₆-alkyl)aminocarbonyl, di-(C₁-C₄-alkyl)aminocarbonyl,    tri-(C₁-C₂)alkylsilyl and (C₁-C₄-alkyl)(C₁-C₄-alkoxy)imino,-   or where the substituents independently of one another may be    selected from the group consisting of phenyl and a 5- or 6-membered    heteroaromatic ring, where phenyl or the ring may optionally be    mono- or polysubstituted by identical or different substituents from    the group consisting of C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,    C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, nitro,    hydroxyl, C₁-C₄-alkoxy and C₁-C₄-haloalkoxy,-   R⁷ represents hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,    C₃-C₆-cy cloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₃-C₆-cycloalkoxy or

-   R⁹ independently of one another represent hydrogen, C₁-C₆-alkyl,    C₃-C₆-cycloalkyl, -C₁-C₆-haloalkyl, halogen, cyano, nitro,    C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio or    C₁-C₄-haloalkylthio,-   p represents 0 to 4,-   Z represents N, CH, CF, CCl, CBr or Cl,-   the compounds of the general formula (I) further comprise N-oxides    and salts,-   and one or snore fungicides from group (II):

Fungicides:

-   (1) Ergosterol biosynthesis inhibitors, for example aldimorph,    azaconazole, bitertanol, bromuconazole, cyproconazole,    diclobutrazole, difenoconazole, diniconazole, diniconazole-M,    dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol,    fenbuconazole, fenhexamid, fenpropidin, fenpropimorph,    fluquinconazole, flurprimidol, flusilazole, flutriafol, furconazole,    furcortazole-cis, hexaconazole, imazalil, imazalil sulphate,    imibenconazole, ipconazole, metconazole, myclobutanil, naftifin,    nuarimol, oxpoconazole, paclobutrazole, pefurazoate, penconazole,    piperalin, prochloraz, propiconazole, prothioconazole, pyributicarb,    pyrifenox, quinconazole, simeconazole, spiroxamine, tebuconazole,    terbinafine, tetraconazole, trialimefon, triadimenol, tridemorph,    triflumizole, triforine, triticonazole, uniconazole, uniconazole-p,    viniconazle, voriconazole,    1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol, methyl    1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole-5-carboxylate,    N′-{5-(difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamide,    N-ethyl-N-methyl-N′-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamide    and O-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl]1H    imidazole-1-carbothioate.-   (2) Respiration inhibitors (respiratory chain inhibitors), such as,    for example, bixafen, boscalid, carboxin, diflumetorim, fenfuram,    fluopyram, flutolanil, fluxapyroxad, furametpyr, furmecyclox,    isopyrazam mixture of the syn-epimeric racemate 1RS,4SR,9RS and of    the anti-epimeric racemate 1RS,4SR,9SR, isopyrazam (anti-epimeric    racemate), isopyrazam (anti-epimeric enantiomer 1R,4S,9S),    isopyrazam (anti-epimeric enantiomer 1S,4R,9R), isopyrazam    (syn-epimeric racemate 1RS,4SR,9RS), isopyrazam (syn-epimeric    enantiomer 1R,4S,9R), isopyrazam (syn-epimeric enantiomer 1S,4R,9S),    mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane,    thifluzamid,    1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide,    3-(difluoramethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide,    N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,    5,8-difluoro-N-[2-(2fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazoline-4-amine,    N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazol-4-carboxamide,    N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide    and    N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide.-   (3) Respiration inhibitors (respiratory chain inhibitors) acting on    complex III of the respiratory chain, for example ametoctradin,    amisulbrom, azoxystrobin, cyazofamid, coumethoxystrobin,    coumoxystrobin, dimoxystrobin, enestroburin, famoxadone, fenamidone,    fenoxystrobin, fluoxastrobin, kresoxim-methyl, metominostrobin,    orysastrobin, picoxystrobin, pyraclostrobin, pyramelostrobin,    pyraoxystrobin, pyribencarb, triclopyricarb, trifloxystrobin,    (2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,    (2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethyliden}amino)oxy]methyl}phenyl)ethanamide,    (2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide,    (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylethenyl]oxy{phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide,    (2E)-2-{2-[({[(2E,3E)-4-(2,6-dichlorophenyl)but-3-en-2-ylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide,    2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide,    5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one,    methyl(2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulphanyl)methyl]phenyl}-3-methoxyprop-2-enoate,    N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide,    2-{2[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide    and    (2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide.-   (4) Mitosis and cell division inhibitors, for example benomyl,    carbendazim, chlorfenazole, diethofencarb, ethaboxam, fluopicolide,    fuberidazole, pencycuron, thiabendazole, thiophanate-methyl,    thiophanate, zoxamide,    5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine    and    3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine.-   (5) Compounds with multisite activity, for example Bordeaux mixture,    captafol, captan, chlorothalonil, copper preparations such as copper    hydroxide, copper naphthenate, copper oxide, copper oxychloride,    copper sulphate, dichlofluanid, dithianon, dodine, dodine free base,    ferbam, fluorofolpet, folpet, guazatine, guazatine acetate,    iminoctadine, iminoctadine albesilate, iminoctadine triacetate,    mancopper, mancozeb, maneb, metiram, metiram zinc, oxine-copper,    propamidine, propineb, sulphur and sulphur preparations, for example    calcium polysulphide, thiram, tolylfluanid, zineb and ziram.-   (6) Resistance inductors, for example acibenzolar-S-methyl,    isotianil, probenazole and tiadinil.-   (7) Amino acid and protein biosynthesis inhibitors, for example    andoprim, blasticidin-S, cyprodinil, kasugamycin, kasugamycin    hydrochloride hydrate, mepanipyrim, pyrimethanil and    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline.-   (8) ATP production inhibitors, for example fentin acetate, fentin    chloride, fentin hydroxide and silthiofam.-   (9) Cell wall synthesis inhibitors, for example benthiavalicarb,    dimethomorph, flumorph, iprovalicarb, mandipropamid, polyoxins,    polyoxorim, validamycin A and valifenalate.-   (10) Lipid and membrane synthesis inhibitors, for example biphenyl,    chloroneb, dicloran, edifenphos, etridiazole, iodocarb, iprobenfos,    isoprothiolane, propamocarb, propamocarb hydrochloride, prothiocarb,    pyrazophos, quintozene, tecnazene and tolclofos-methyl.-   (11) Melanin biosynthesis inhibitors, such as, for example,    carpropamid, diclocymet, fenoxanil, phthalide, pyroquilon,    tricyclazole and    2,2,2-trifluoroethyl{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate.-   (12) Nucleic acid synthesis inhibitors, for example benalaxyl,    benalaxyl-M (kiralaxyl), bupirimate, clozylacon, dimethirimol,    ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M(mefenoxam),    ofurace, oxadixyl and oxolinic acid.-   (13) Signal transduction inhibitors, for example chlozolinate,    fenpiclonil, fludioxonil, iprodione, procymidone, quinoxyfen and    vinclozolin.-   (14) Decouplers, for example binaparyl, dinocap, ferimzone,    fluazinam and meptyldinocap.-   (15) Further compounds, for example benthiazole, bethoxazin,    capsimycin, carvone, chinomethionat, pyriofenone (chlazafenone),    cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet,    debacarb, dichlorophen, diclomezine, difenzoquat, difenzoquat    methylsulphate, diphenylamine, ecomat, fenpyrazamine, flumetover,    fluoromide, flusulfamide, flutianil, fosetyl-aluminium,    fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin,    methasulfocarb, methyl isothiocyanate, metrafenon, mildiomyacin,    natamycin, nickel dimethyldithiocarbamate, nitrothal-isopropyl,    octhilinone, oxamocarb, oxyfenthiin, pentachlorophenol and salts    thereof, phenothrin, phosphoric acid and salts thereof,    propamocarb-fosetylate, propanosine-sodium, proquinazid, pyrimorph,    pyrrolnitrin, tebufloquin, tecloftalam, tolnifanid, triazoxide,    trichlamide, zarilamide,    (3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl    2-methylpropanoate,    1-(4-{-4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,    1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2yl}piperidin-1-yl)-2-[5-methyl-3-(trifluromethyl)-1H-pyrazol-1-yl]ethanone,    1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,    1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl    1H-imidazole-1-carboxylate,    2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine,    2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one,    2,6-dimethyl-1-H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone,    2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,    2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,    2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone,    2-butoxy-6-iodo-3-propyl-4H-chromen-4-one,    2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine,    2-phenylphenol and salts thereof,    3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,    3,4,5-trichloropyridine-2,6-dicarbonitrile,    3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine,    3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine,    4-(4-chlorophenyl)-5-2,6-difluorophenyl)-3,6-dimethylpyridazine,    5-amino-1,3,4-thiadiazole-2-thiol,    5-chloro-N′-phenyl-N′-(prop-2-yn-1-yl)thiophene-2-sulphonohydrazide,    5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidine-4-amine,    5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidine-4-amine,    5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,    ethyl(2Z)-3-amino-2-cyano-3-phenylprop-2-enoate,    N′-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimideformamide,    N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,    N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,    N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide,    N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide,    N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide,    N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,    N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,    N′-{4-[(3-tert-butyl-4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methylimidoformamide,    N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide,    N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,    N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,    pentyl{6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylidene]amino}oxy)methyl]pyridin-2-yl}carbamate,    phenazine-1-carboxylic acid, quinolin-8-ol, quinolin-8-ol sulphate    (2:1) and    tert-butyl{6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate.-   (16) further compounds, for example    1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,    N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,    N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,    N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,    5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,    2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,    3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,    N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide,    N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,    2-chloro-N-(4′-ethynylbiphenyl-2-yl)pyridine-3-carboxamide,    2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,    4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide,    5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,    2-chloro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,    3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,    5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl-]-1,3-dimethyl-1H-pyrazole-4-carboxamide,    2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,    (5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanone    and    N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N2-(methylsulphonyl)valinamide,    4-oxo-4-[(2-phenylethyl)amino]butanoic acid and    but-3-yn-1-yl{6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate    are highly suitable for controlling unwanted animal pests such as    insects, acari and/or nematodes and also unwanted phytopathogenic    fungi.

If, within this description, the short form of the common name of anactive compound is used, this in each case encompasses all commonderivatives, such as the esters and salts, and isomers, especiallyoptical isomers, especially the commercial form or forms. If an ester orsalt is referred to by the common name, this also refers in each case toall other common derivatives, such as other esters and salts, the freeacids and neutral compounds, and isomers, especially optical isomers,especially the commercial form or forms. The chemical compound namesmentioned refer to at least one of the compounds encompassed by thecommon name, frequently a preferred compound.

Surprisingly, the insecticidal, acaricidal, nematicidal and fungicidalaction of the active compound combinations according to the invention isconsiderably higher than the total of the actions of the individualactive compounds. A true synergistic effect which could not have beenpredicted exists, not just a complementation of action.

DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT

Preference is given to combinations comprising at least one of theactive compounds of the formula (I) mentioned as being preferred,particularly preferred, very particularly preferred or especiallypreferred and one or more active compounds selected from group (II).

Preferred, particularly preferred, very particularly preferred orespecially preferred are active compounds of the formula (I) where

-   R¹ preferably represents hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl,    C₂-C₆-alkynyl, C₃-C₆-cycloalkyl, cyano-(C₁-C₆-alkyl),    C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,    C₁-C₄-alkoxy-C₁-C₄-alkyl, C₁-C₄-alkylthio-C₁-C₄-alkyl,    C₁-C₄-alkylsulphinyl-C₁-C₄-alkyl or C₁-C₄-alkylsulphonyl-C₁-C₄    -alkyl,-   R¹ particularly preferably represents hydrogen, methyl, ethyl,    cyclopropyl, cyanomethyl, methoxymethyl, methylthiomethyl,    methylsulphinylmethyl or methylsulphonylmethyl,-   R¹ very particularly preferably represents hydrogen,-   R² preferably represents hydrogen or C₁-C₆-alkyl,-   R² particularly preferably represents hydrogen or methyl,-   R² very particularly preferably represents hydrogen,-   R³ preferably represents hydrogen or represents C₁-C₄-alkyl,    C₁-C₄-alkoxy, C₂-C₄-alkenyl, C₂-C₄-alkynyl, C₃-C₆-cycloalkyl, each    of which is optionally mono- or polysubstituted by identical or    different substituents, where the substituents independently of one    another may be selected from the group consisting of halogen, cyano,    carboxyl, carbamoyl, nitro, hydroxyl, C₁-C₄-alkyl, C₁-C₄-haloalkyl,    C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-alkoxycarbonyl,    C₁-C₄-alkylcarbonyl or a phenyl ring or a 4-, 5- or 6-membered    aromatic, partially saturated or saturated heterocyclic ring, where    the phenyl ring or heterocyclic ring is optionally mono- or    polysubstituted by identical or different substituents and where the    substituents independently of one another may be selected from the    group consisting of hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl,    C₂-C₆-alkynyl, C₃-C₆-cycloakyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl,    carbamoyl, NO₂, hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,    C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,    C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,    C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,    C₃-C₆-cycloalkylamino, (C₁-C₆-alkyl)carbonyl, (C₁-C₆-alkoxy)carbonyl    or-   R³ preferably represents C₂-C₄-alkoxycarbonyl, C₂-C₄-alkylcarbonyl,    C₂-C₄-alkylaminocarbonyl or C₂-C₄-dialkylaminocarbonyl, or-   R³ represents a phenyl ring, a 5- or 6-membered aromatic    heterocyclic ring or a 4-, 5- or 6-membered partially saturated or    saturated heterocyclic ring which may contain 1-3 heteroatoms from    the group consisting of N, S and O, where the phenyl ring or    heterocyclic ring is optionally mono- or polysubstituted by    identical or different substituents, and where the substituents    independently of one another may be selected from the group    consisting of hydrogen, C₁-C₄-alkyl, C₂-C₄-alkenyl, C₂-C₄-alkynyl,    C₃-C₆-cycloalkyl, C₁-C₄-haloalkyl, C₂-C₄-haloalkenyl,    C₂-C₄-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl,    carbamoyl, NO₂, hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,    C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,    C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,    C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,    C₃-C₆-cycloalkylamino, (C₁-C₄-alkyl)carbonyl and    (C₁-C₄-alkoxy)carbonyl,-   R³ particularly preferably represents hydrogen or represents    C₁-C₄-alkyl or C₃-C₆-cycloalkyl, each of which is optionally mono-    or polysubstituted by identical or different substituents, where the    substituents independently of one another may be selected from the    group consisting of halogen, cyano, carboxyl, hydroxyl, C₁-C₄-alkyl,    C₁-C₄-haloalkyl, C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,    C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,    C₂-C₄-alkoxycarbonyl, C₂-C₆-alkylcarbonyl and a phenyl ring and a    4-, 5- or 6-membered aromatic, partially saturated or saturated    heterocyclic ring, where the phenyl ring or heterocyclic ring is    optionally mono- or polysubstituted by identical or different    substituents, and where the substituents independently of one    another may be selected from the group consisting of hydrogen,    C₁-C₄-alkyl, C₃-C₆-cycloalkyl, C₁-C₄-haloalkyl, C₂-C₄-haloalkenyl,    C₂-C₄-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, hydroxyl,    C₁-C₄-alkoxy and C₁-C₄-haloalkoxy, or-   R³ particularly preferably represents C₂-C₄-alkoxycarbonyl,    C₂-C₄-alkylcarbonyl or C₂-C₄-alkylaminocarbonyl, or-   R³ particularly preferably represents a phenyl ring, a 5- or    6-membered aromatic heterocyclic ring or a 4-, 5- or 6-membered    partially saturated or saturated heterocyclic ring which may contain    1-3 heteroatoms from the group consisting of N, S and O, where the    phenyl ring or heterocyclic ring is optionally mono- or    polysubstituted by identical or different substituents, and where    the substituents indepenedently of one another may be selected from    the group consisting of hydrogen, C₁-C₄-alkyl, C₂-C₄-alkenyl,    C₂-C₄-alkenyl, C₃-C₆-cycloalkyl, C₁-C₄-haloalkyl, C₂-C₄-haloalkenyl,    C₂-C₄-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, carbamoyl,    NO₂, hydroxyl, C₁-C₄-alkoxy and C₁-C₄-haloalkoxy, or-   R³ very particularly preferably represents hydrogen, methyl, ethyl,    n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, text-butyl,    cyclopropyl, cyclobutyl, azetidine, oxetane, thietane, pyrrolidine,    pyrazolidine, imidazolidine, imidazolidinone, tetrahydrofuran,    tetrahydrothiophene, tetrahydrothiophene dioxide, thiazoline,    thiazolidine, piperidine, piperazine, tetrahydropyran,    dihydrofuranone, dioxane, morpholine, thiomorpholine, thiomorpholine    dioxide, phenyl or pyridyl, or-   R³ especially preferably represents hydrogen, methyl, isopropyl,    cyclopropyl or tert-butyl.-   R⁴ preferably represents hydrogen, C₁-C₄-alkyl, C₁-C₄-haloalkyl,    halogen, cyano, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio or    C₁-C₄-haloalkylthio,-   two adjacent radicals R⁴ likewise preferably represent —(CH₂)₃—,    —(CH₂)₄—, —(CH₂)₅—, —(CH═CH—)₂—, —OCH₂O—, —O(CH₂)₂O—, —OCF₂O—,    —(CF₂)₂O—, —O(CF₂)₂O—, —(CH═CH—CH═N)— or —(CH═CH—N═CH)—,-   R⁴ particularly preferably represents hydrogen, C₁-C₄-alkyl,    C₁-C₂-haloalkyl, halogen, cyano or C₁-C₂-haloaikoxy,-   two adjacent radicals R⁴ particularly preferably represent —(CH₂)₄—,    —(CH═CH—)₂—, —O(CH₂)₂O—, —O(CF₂)₂O—, —(CH═CH—CH═N)— or    —(CH═CH—N═CH)—,-   R⁴ very particularly preferably represents hydrogen, methyl,    trifluoromethyl, cyano, fluorine, chlorine, bromine, iodine or    trifluoromethoxy. Moreover, two adjacent radicals R⁴ very    particularly preferably represent —(CH₂)₄— or —(CH═CH—)₂—,-   R⁴ especially preferably represents chlorine, fluorine or bromine,-   R⁴ furthermore especially preferably represents iodine or cyano,-   two adjacent radicals R⁴ especially preferably represent —(CH═CH—)₂-   n preferably represents 0, 1 or 2,-   n particularly preferably represents 1 or 2,-   n very particularly preferably represents 1,-   R⁵ preferably represents C₁-C₄-alkyl, C₃-C₆-cycloalkyl,    C₁-C₄-haloalkyl, C₁-C₆-halocycloalkyl, C₂-C₆-alkenyl,    C₂-C₄-haloalkenyl, C₂-C₄-alkynyl, C₂-C₄-haloalkynyl, C₁-C₄-alkoxy,    C₁-C₄-haloalkoxy, C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl,    C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,    C₁-C₄-haloalkylsulphonyl, halogen, cyano, nitro or    C₃-C₆-trialkylsilyl,-   R⁵ particularly preferably represents C₁-C₄-alkyl, C₃-C₆-cycloalkyl,    C₁-C₄-haloalkyl, C₁-C₆-halocycloalkyl, C₂-C₆-alkenyl,    C₂-C₄-haloalkenyl, C₂-C₄-alkynyl, C₂-C₄-haloalkynyl, C₁-C₄-alkoxy,    C₁-C₄-haloalkoxy, fluorine, chlorine, bromine, iodine, cyano, nitro    or C₃-C₆-trialkylsilyl,-   R⁵ very particularly preferably represents methyl, fluorine,    chlorine, bromine or iodine,-   R⁵ especially referably represents methyl or chlorine,-   Q_(X) preferably represents a 5- or 6-membered heteroaromatic ring    which is optionally mono- or polysubstituted by identical or    different R⁷ and which may contain 1-3 heteroatoms from the group    consisting of N, O and S, or represents phenyl,-   Q_(X) particularly preferably represents a 5- or 6-membered ring    selected from the group consisting of furan, thiophene, triazole,    imidazole, thiazole, oxazole, isoxazole, isothiazole, thiadiazole,    oxadiazole, pyrrole, pyridine, pyrimidine, pyridazine, pyrazine,    phenyl or pyrazole, which ring is optionally mono- or    polysubstituted by identical or different R⁷,-   Q_(X) very particularly preferably represents thiazole, oxazole,    pyrrole, imidazole, triazole, pyrimidine, phenyl or represents    pyrazole which is monosubstituted by the group R⁷,

-   where Z, R and p may have the general definitions given above or the    preferred or particularly preferred definitions given below,-   A preferably represents optionally mono- or polysubstituted    —(C₁-C₄-alkylene)-, —C₂-C₄-alkenylene)-, —(C₂-C₄-alkynylene)-,    —R⁸—(C₃-C₆-cycloalkyl)-R⁸—, —R⁸—O—R⁸—, —R⁸—S—R⁸—, —R⁸—S(═O)—R⁸—,    —R⁸—S(═O)₂—R⁸—, —R⁸—NH—(C₁-C₄-alkyl)-, —R⁸—N(C₁-C₄-alkyl)-R⁸,    —R⁸—C═NO(C₁-C₄-alkyl), —R⁸—C(═O)—R⁸, —R⁸—C(═S)—R⁸, —R⁸—C(═O)NH—R⁸,    R⁸—C(═O)N(C₁-C₄-alkyl)-R⁸, —R⁸—S(═O)₂NH—R⁸,    —R⁸—S(═O)₂N(C₁-C₄-alkyl)-R⁸, —R⁸—NH(C═O)O—R⁸,    —R⁸—N(C₁-C₄-alkyl)-(C═O)O—R⁸, —R⁸—NH(C═O)NH—R⁸, —R⁸—NHS(═O)₂—R⁸,    —R⁸—N(C₁-C₄-alkyl)S(═O)₂—R⁸, R⁸—NH—R⁸, R⁸—C(═O)—C(═O)—R⁸,    R⁸—C(OH)—R⁸ or R⁸-Qz-R⁸,-   where the substituents independently of one another may be selected    from the group consisting of halogen, cyano, nitro, hydroxyl,    C₁-C₆-alkyl, C₁-C₆-alkoxy and halo-C₁-C₆-alkyl,-   where Q_(Z) may have the general definitions given above or the    preferred or particularly preferred definitions given below,-   A particularly preferably represents —CH₂—, —CH₂O—, —CH₂OCH₂—,    —CH₂S—, —CH₂SCH₂—, —CH₂N(C₁-C₄-alkyl)-, —CH₂N(C₁-C₄-alkyl)CH₂—,    —CH(Hal)-, —C(Hal)₂-, —CH(CN)—, CH₂(CO)—, CH₂(CS)—, CH₂CH(OH)—,    -cyclopropyl-, CH₂(CO)CH₂—, —CH(C₁-C₄alkyl)-, —C(di-C₁-C₆-alkyl)-,    —CH₂CH₂—, —CH═CH—, —C≡C—, —C═NO(C₁-C₆-alkyl) or    —C(═O)(C₁-C₄-alkyl)-,-   A very particularly preferably represents —CH₂—, —CH(CH₃), C(CH₃)₂,    —CH₂CH²—, —CH(CN)—, —CH₂O— or —C(═O)—CH₂—,-   A especially preferably represents CH₂, CH(CH₃), —CH₂O— or    —C(═O)—CH₂—,-   Q_(Z) preferably represents a 3- or 4-membered partially saturated    or saturated or a 5- or 6-membered partially saturated, saturated or    aromatic ring, where the ring may optionally contain 1-3 heteroatoms    from the group consisting of N, S and O,-   where the ring is optionally mono- or polysubstituted by identical    or different substituents, and where the substituents independently    of one another may be selected from the group consisting of    hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynl,    C₁-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, hydroxyl,    C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,    C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio,    C₁-C₄-haloalkysulphinyl and C₁-C₄-haloalkylsulphonyl,-   Q_(Z) particularly preferably represents a 3- or 4-membered    partially saturated or saturated or a 5-membered partially    saturated, saturated or aromatic ring, where the ring may optionally    contain 1-2 heteroatoms from the group consisting of N, S and O,-   where the ring is optionally mono- or polysubstituted by identical    or fferent substituents, and where the substituents independently of    one another may be selected from the group consisting of hydrogen,    C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,    C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,    C₃-C₆-halocycloalkyl, halogen, cyano, hydroxyl, C₁-C₄-alkoxy,    C₁-C₄-haloalkoxy, C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl,    C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl    and C₁-C₄-haloalkylsulphonyl,-   Q_(Z) very particularly preferably represents azetidine, oxetane or    thietane, pyrrolidine, pyrroline, pyrazolidine, pyrazoline,    imidazolidine, imidazolidone, imidazoline, tetrahydrofuran,    tetrahydrothiophene, thiazolidine, isothiazolidine or isoxazoline,-   which is optionally mono- or polysubstituted by identical or    different substituents, and where the substituents independently of    one another may be selected from the group consisting of hydrogen,    methyl, ethyl, isopropyl, hydroxyl, methoxy, trifluoromethoxy,    fluorine, chlorine, bromine, cyano, difluoromethyl, trifluoromethyl,-   R⁷ preferably represents C₁-C₆-alkyl or represents the radical

-   R⁷ furthermore preferably represents C₃-C₆-cycloalkoxy,-   R⁷ particularly preferably represents methyl or represents the    radical

-   R⁹ independently of one another preferably represent hydrogen,    halogen, cyano, C₁-C₆-alkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkyl,    C₁-C₄-haloalkoxy, C₁-C₄-haloalkylsulphonyl or    (C₁-C₄-alkyl)-C₁-C₄-alkoxyimino,-   R⁹ independently of one another particularly preferably represent    hydrogen, halogen, cyano or C₁-C₄-haloalkyl,-   R⁹ independently of one another very particularly preferably    represent fluorine, chlorine or bromine,-   R⁹ especially preferably represents chlorine,-   p preferably represents 1, 2 or 3,-   p particularly preferably represents 1 or 2,-   p very particularly preferably represents 1,-   Z Preferably represents N, CH, CF, CCl, CBr or CI,-   Z particularly preferably represents N, CH, CF, CCl or CBr,-   Z very particularly preferably represents N, CCl or CH,-   R⁸ preferably represents straight-chain or branched    —(C₁-C₄-alkylene)- or represents a direct bond,-   R⁸ particularly preferably represents methyl, ethyl, propyl,    isopropyl, n-butyl, sec-butyl or isobutyl or a direct bond,-   R⁸ very particularly preferably represents methyl or ethyl or a    direct bond,-   Q_(Y) Preferably represents a 5- or 6-membered partially saturated    or saturated heterocyclic or heteroaromatic ring or an aromatic 8-,    9- or 10-membered fused heterobicyclic ring system, where the    heteroatoms may be selected from the group consisting of N, S and O,    where the ring or the ring system is optionally mono- or    polysubstituted by identical or different substituents, and where    the substituents independently of one another may be selected from    the group consisting of hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl,    C₂-C₆-alkynyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl,    carbamoyl, nitro, hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,    C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,    C₁-C₄-haloalkylthio, C₁-C₄-haloalkysulphinyl,    C₁-C₄-haloalkylsulphonyl,-   or where the substituents independently of one another may be    selected from the group consisting of phenyl and a 5- or 6-membered    heteroaromatic ring, where phenyl or the ring may optionally be    mono- or polysubstituted by identical or different substituents from    the group consisting of C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,    C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocyeloalkyl, halogen, cyano, nitro,    hydroxyl, C₂-C₄-alkoxy and C₁-C₄-haloalkoxy,-   Q_(Y) particularly preferably represents an optionally mono- or    polysubstituted 5- or 6-membered heteroaromatic ring from the group    consisting of Q-1 to Q-53 and Q-58 to Q-59, Q62 to Q63, an aromatic    9-membered fused heterobicyclic ring system Q-54 to Q-56 or a    5-membered heterocyclic ring Q-60 to Q-61, where the substituents    independently of one another may be selected from the group    consisting of C₁-C₃-alkyl, C₁-C₃-haloalkyl, C₁-C₂-alkoxy, halogen,    cyano, hydroxyl, nitro or C₁-C₂-haloalkoxy,-   or where the substituents independently of one another may be    selected from the group consisting of phenyl and a 5- or 6-membered    heteroaromatic ring, where phenyl or the ring may optionally be    mono- or polysubstituted by identical or different substituents from    the group consisting of C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆alkynyl,    C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, NO₂,    hydroxyl, C₁-C₄-alkoxy and C₁-C₄-haloalkoxy,-   Q_(Y) very particularly preferably represents an optionally mono- or    polysubstituted 5- or 6-membered heteroaromatic ring from the group    consisting of Q-36 to Q-40, Q43, Q-58 to Q-59, Q62, Q63, an aromatic    9-membered fused heterobicyclic ring system Q-54 to Q-56 or a    5-membered heterocyclic ring Q-60 to Q-61, where the substituents    independently of one another may be selected from the group    consisting of C₁-C₃-alkyl, C₁-C₃-haloalkyl, C₁-C₂-alkoxy, halogen,    cyano, hydroxyl, nitro or C₁-C₂-haloalkoxy,-   or where the substituents independently of one another may be    selected from the group consisting of phenyl and a 5- or 6-membered    heteroaromatic ring, where phenyl or the ring may optionally be    mono- or polysubstituted by identical or different substituents from    the group consisting of C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,    C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,    C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, nitro,    C₁-C₄-alkoxy and C₁-C₄-haloalkoxy,-   Q_(Y) especially preferably represents a heteroaromatic ring from    the group consisting of Q-37, Q-38, Q-39, Q-40, Q43, Q-58, Q-59, Q62    and Q63 which is optionally mono- or polysubstituted by identical or    different substituents, or represents a 5-membered heterocyclic ring    Q-60, where the substituents independently of one another may be    selected from the group consisting of methyl, ethyl, cyclopropyl,    tert-butyl, chlorine, fluorine, iodine, bromo, cyano, nitro,    difluoromethyl, trifluoromethyl, pentafluoroethyl,    n-heptafluoropropyl and isoheptafluoropropyl-   or where the substituents independently of one another may be    selected from the group consisting of phenyl and a 5- or 6-membered    heteroaromatic ring, where the substituents independently of one    another may be selected from the group consisting of methyl, ethyl,    cyclopropyl, tert-butyl, chlorine, fluorine, iodine, bromine, cyano,    nitro, difluoromethyl, trifluoromethyl, pentafluorethyl,    n-heptafluoropropyl and isoheptafluoropropyl.

Independently of one another, the rings or ring systems listed above mayadditionally be substituted by oxo, thioxo, (═O)═NH, (═O)═N—CN, (═O)₂.Tetrahydrothiophene dioxide and imidazolidone may be mentioned by way ofexample.

In this case, the oxo group as substituent at a ring carbon atom, forexample, is a carbonyl group in the heterocyclic ring. As a result,lactones and lactarns are preferably also included. The oxo group mayalso be present at the hetero ring atoms which can occur in variousoxidation states, for example at N and S, in which case they form, forexample, the divalent groups —N(O)—, —S(O)— (also abbreviated as SO) and—S(O)₂— (also abbreviated as SO₂) in the heterocyclic ring. In the caseof —N(O)— and —S(O)— groups, in each case both enantiomers are included.

At a heterocyclic ring, substituents other than the oxo group may alsobe attached to a heteroatom, for example at a nitrogen atom, if duringthe process a hydrogen atom at the nitrogen atom of the parent structureis replaced. In the case of the nitrogen atom and also other heteroatomssuch as, for example, the sulphur atom, further substitution withformation of quaternary ammonium compounds or sulphonium compounds isalso possible.

In particular, the compounds of the formula (I) can be present in theform of various regioisomers. For example in the form of mixtures ofcompounds having, the definition Q62 or Q63 or in the form of mixturesof Q58 and Q59. Accordingly, the invention also embraces active compoundcombinations comprising mixtures of compounds of the formula (I) whereQ_(Y) has the meanings Q62 and Q63, and also Q58 and Q59, and thecompounds may be present in various mixing ratios, and one or moreactive compounds from group (II). Preference is given here to mixingratios of compounds of the formula (I) in which the radical Q_(Y)represents Q62 or Q58 to compounds of the formula (I) in which theradical Qy represents Q63 or Q59 of from 60:40 to 99:1, particularlypreferably from 70:30 to 97:3, very particularly preferably from 80:20to 95:5. Special preference is given to the following mixing ratios of acompound of the formula (I) where Q_(Y)has the meaning Q62 or Q58 to acompound of the formula (I) where Q_(Y) has the meaning Q63 or Q59:80:20; 81:19; 82:18; 83:17; 84:16; 85:15, 86:14; 87:13; 88:12; 89:11;90:10, 91:9; 92:8; 93:7; 96:6; 95:5.

Preference is furthermore given to active compound combinationscomprising a east one active compound of the formula (I-1)

in which

-   R³ represents hydrogen or represents C₁-C₆-alkyl, C₁-C₆-alkoxy,    C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₁₂-cycloalkyl,    C₃-C₁₂-cycloalkyl-C₁-C₆-alkyl, each of which is optionally mono- or    polysubstituted by identical or different substituents, where the    substituents independently of one another may be selected from the    group consisting of halogen, amino, cyano, nitro, hydroxyl,    C₁-C₆-alkyl, C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,    C₁-C₄-alkylthio, C₂-C₆-alkoxycarbonyl, C₁-C₆-alkylcarbonyl,    C₃-C₆-cycloalkylamino and a 5- or 6-membered heteroaromatic ring,-   R⁴ represents halogen, cyano or methyl,-   R⁵ represents methyl or chlorine,-   Z represents N, CCl or CH,-   Qy represents an optionally mono- or polysubstituted 5- or    6-membered heteroaromatic ring from the group consisting of Q-36 to    Q-40, Q43, Q-58 to Q-59, Q62, Q63, an aromatic 9-membered fused    heterobicyclic ring system Q-54 to Q-56 or a 5-membered heterocyclic    ring Q-60 to Q-61, where the substituents independently of one    another may be selected from the group consisting of C₁-C₃-alkyl,    C₁-C₃-haloalkyl, C₁-C₂-alkoxy, halogen, cyano, hydroxyl, nitro or    C₁-C₂-haloalkoxy,-   where the compounds of the formula (I-1) may be present in the form    of salts,-   and one or more active compounds selected from group (II).

Particular preference is given to combinations comprising at least oneof the active compounds of the formula (I-1) mentioned as beingpreferred, particularly preferred, very particularly preferred orespecially preferred and one or more active compounds selected fromgroup (II).

Preferred, particularly preferred, very particularly preferred orespecially preferred are active compounds of the formula (I-1) where

-   R³ preferably represents hydrogen or represents C₁-C₆-alkyl,    C₁-C₆-alkoxy, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,    C₃-C₆-cycloalkyl-C₁-C₆alkyl, each of which is optionally mono- or    polysubstituted by identical or different substituents, where the    substituents independently of one another may be selected from the    group consisting of halogen, cyano, amino, hydroxyl, C₁-C₆-alkyl,    C₁-C₄-alkoxy, C₁-C₄-halaolkoxy, C₁-C₄-alkylthio, C₃-C₆-cycloalkyl    and a 5- or 6-membered heteroaromatic ring which contains 1-2    heteroatoms from the group consisting of N, O and S, where two    oxygen atoms in the ring are not adjacent,-   R³ particularly preferably represents one of the radicals below

-   R⁴ preferably represents halogen, cyano or methyl,-   R⁴ particularly preferably represents chlorine or cyano,-   R⁴ also particularly preferably represents bromine, fluorine, iodine    or methyl,-   R⁵ preferably and particularly preferably represents methyl,-   Z preferably represents N or CH,-   Q_(Y) preferably represents a heteroaromatic ring from the group    consisting of Q-37, Q-38, Q-39, Q-40, Q43, Q-58, Q-59, Q62 and Q63    which is optionally mono- or polysubstituted by identical or    different substituents, or represents a 5-membered heterocyclic ring    Q-60, where the substituents independently of one another may be    selected from the group consisting of methyl, ethyl, cyclopropyl,    tert-butyl, chlorine, fluorine, iodine, bromo, cyano, nitro,    difluoromethyl, trifluoromethyl, pentafluoroethyl,    n-heptafluoropropyl and isoheptafluoropropyl,-   Q_(Y) particularly preferably represents a heteroaromatic ring from    the group consisting of Q-58 and Q-59 which is optionally mono- or    polysubstituted by identical or different substituents, where the    substituents independently of one another may be selected from the    group consisting of methyl, ethyl, cyclopropyl, tert-butyl,    difluoromethyl, trifluoromethyl, pentafluoroethyl,    n-heptafluoropropyl and isoheptafluoropropyl.

In particular, the compounds of the formula (I-1) can be present in theform of various regioisomers. For example in the form of mixtures ofcompounds having the definition Q62 or Q63 or in the form of mixtures ofQ58 and Q59. Accordingly, the invention also embraces active compoundcombinations comprising mixtures of compounds of the formula (I-1) whereQ_(Y) has the meanings Q62 and Q63, and also Q58 and Q59, and thecompounds may be present in various mixing ratios, and one or moreactive compounds from group (II). Preference is given here to mixingratios of compounds of the formula (I) In which the radical Q_(Y)represents Q62 or Q58 to compounds of the formula (I) in which theradical Qy represents Q63 or Q59 of from 60;40 to 99:1, particularlypreferably from 70:30 to 97:3, very particularly preferably from 80:20to 95:5. Special preference is given to the following mixing ratios of acompound of the formula (I) where Q_(Y) has the meaning Q62 or Q58 to acompound of the formula (I) where Q_(Y) has the meaning Q63 or Q59:80:20; 81:19; 82;18; 83:17; 84;16; 85:15, 86:14; 87:13; 88:12; 89:11;90:10, 91:9; 92:8; 93:7; 96:6; 95:5.

Preference is furthermore given to active compound combinationscomprising at least one active compound of the general formula (I) or(I-1) and an active compound of group (II) selected from the groupconsisting of

-   bitertanol-   bixafen-   carpropamid-   fenamidone-   fluopicolide-   fluopyram-   fluoxastrobin-   fluquinconazole-   isotianil-   metominostrobin-   pencycuron-   penflufen-   prochloraz-   propamocarb-   propineb-   prothioconazole-   spiroxamine-   tebuconazole-   triadimenol-   triazoxide-   trifloxystrobin-   ametoctradin-   azoxystrobin-   benthiavalicarb-   boscalid-   carbendazim-   carboxin-   chlorothalonil-   cymoxanil-   cyproconazole-   cyprodinil-   cyazofamid-   difenoconazole-   dimoxystrobin-   epoxiconazole-   fenpropidin-   ferimzone-   fluazinam-   fludioxonil-   flutolanil-   flutriafol-   fluxapyroxad-   gentamycin-   hymexazol-   imazalil-   ipconazole-   isoprothiolane-   isopyrazam-   kasugamycin-   mancozeb-   mandipropamid-   maneb-   mefenoxam-   metalaxyl-   metconazole-   metrafenone-   orysastrobin-   penthiopyrad-   picoxystrobin-   probenazole-   propiconazole-   proquinazid-   pyraclostrobin-   pyrimethanil-   pyroquilon-   quinoxyfen-   sedaxane-   tetraconazole-   thiophanate-methyl-   thiram-   tolclofos-methyl-   tricyclazole-   tritconazole-   validamycin-   fosetyl-aluminium.

Particular preference is furthermore given to active compoundcombinations comprising at least one active compound of the generalformula (I) or (I -1) and an active compound of group (II) selected fromthe group consisting of

-   bitertanol-   bixafen-   carpropamid-   fenamidone-   fluopicolide-   fluopyram-   fluoxastrobin-   fluquinconazole-   isotianil-   metominostrobin-   pencycuron-   penflufen-   prochloraz-   propamocarb-   propineb-   prothioconazole-   spiroxamine-   tebuconazole-   triadimenol-   triazoxide-   trifloxystrobin-   fludioxonil-   ipconazole-   imazalil-   mancozeb-   metalaxyl-   mefenoxam-   sedaxane-   azoxystrobin-   orysastrobin-   carbendazim-   boscalid-   flutolanil-   fluxapyroxad-   fosetyl-aluminium

Very particular preference is given to active compound combinationscomprising exactly one active compound of the formulae (I-1-1) to(I-1-60) and one or more active compounds of group (II).

Very particular preference is furthermore given to active compoundcombinations comprising the mixtures given below of active compounds ofthe formulae (I-1-1) to (I -1-60) and one or more active compounds ofgroup (II).

These mixtures are preferably present in a mixing ratio of from 80:20 to99:1. In an exemplary manner, mention may be made of the mixture I-1-1/I-1-7, where the compound of the formula I-1-1 and the compound ofthe formula I -1-7 are present in a mixing ratio from 80:20 to 99:1, Inan exemplary manner, mention may also be made of the mixture I-1-2/I-1-8, where the compound of the formula I-1-2 and the compound ofthe formula I-1-8 are present in a mixing ratio from 80:20 to 99:1.

-   I-1-1-/I-1-7,-   I-1-2/I-1-8,-   I-1-3/I-1-9,-   I-1-4/I-1-10,-   I-1-5/I-1-11,-   I-1-6/I-1-12,-   I-1-13/I1-1-19,-   I -1-14/I-1-20,-   I-1-15/I-1-21,-   I-1-16/I-1-22,-   I-1-17/I-1-23,-   I-1-18/I-1-24,-   I-1-25/I-1-31,-   I-1-26/I-1-32,-   I-1-27/I-1-33,-   I-1-28/I-1-34,-   I-1-29/I-1-35,-   I-1-30/I-1-36,-   I-1-37/I-1-43,-   I -1-38/I-1-44,-   I-1-39/I-1-45,-   I-1-40/I-1-46,-   I-1-41/I-1-47,-   I-1-42/I-1-48,-   I-1-49/I-1-55,-   I-1-50/I-1-56,-   I-1-51/I-1-57,-   I-1-52/I-1-58,-   I-1-53/I-1-59,-   I-1-54/I-1-60.

Especially preferred are combinations comprising the active compound(I-1-1) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-2) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound (I-1-3) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-4) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-5) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-6) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-7) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-8) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-9) and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-10) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-11) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-12) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-13) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-14) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-15) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-16) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-17) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-18) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-19) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-20)and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-21) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-22) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-23) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-24) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-25) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-26) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-27) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-28) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-29) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-30) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-31) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-32) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-32) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-34) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-35) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-36) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-37) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-38) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-39) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-40) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-41) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-42) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-43) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-44) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-45) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-46) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-47) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-48) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-49) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-50) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-51) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-52) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-53) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-54) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-55) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-56) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-57) and exactly one active compound of group II in the mixing sgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-58) and exactly one active compound of group II in the mixingratios given in Table 1.

Especially preferred are combinations comprising the active compound(I-1-59 and exactly one active compound of group II in the mixing ratiosgiven in Table 1.

Especially preferred are combinations comprising the active compound(I-1-60) and exactly one active compound of group II in the mixingratios given in Table 1.

In addition, the active compound combinations may also con vise otherfungicidally, acaricidally or insecticidally active components foradmixture.

If the active compounds are present in the active compound combinationsaccording to the invention in certain weight ratios, the enhancedactivity becomes evident. However, the weight ratios of the activecompounds in the active compound combinations can be varied within arelatively wide range. In general, the combinations according to theinvention comprise active compounds of the formula (I) to mixing partnerof group (II) in a ratio from 625:1 to 1:625; preferably in thepreferred and particularly preferred mixing ratios listed in Table 1below:

-   -   the mixing ratios are based on weight ratios. The ratio is to be        understood as active compound of the formula (I): mixing partner        to formula (I): mixing partner

TABLE 1 particularly very particularly preferred preferred preferredMixing partner mixing ratio mixing ratio mixing ratio bitertanol 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 bixafen 625:1 to 1:625 125:1 to1:125 25:1 to 1:25 carpropamid 625:1 to 1:625 125:1 to 1:125 25:1 to1:25 fenamidone 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25fosetyl-aluminium 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25fluopicolide 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 fluopyram 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 fluoxastrobin 625:1 to 1:625 125:1to 1:125 25:1 to 1:25 fluquinconazole 625:1 to 1:625 125:1 to 1:125 25:1to 1:25 isotianil 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25metominostrobin 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 pencycuron625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 penflufen 625:1 to 1:625125:1 to 1:125 25:1 to 1:25 prochloraz 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 propamocarb 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25propineb 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 prothioconazole625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 spiroxamine 625:1 to 1:625125:1 to 1:125 25:1 to 1:25 tebuconazole 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 triadimenol 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25triazoxide 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 trifloxystrobin625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 ametoctradin 625:1 to 1:625125:1 to 1:125 25:1 to 1:25 azoxystrobin 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 benthiavalicarb 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25boscalid 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 carbendazim 625:1 to1:625 125:1 to 1:125 25:1 to 1:25 carboxin 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 chlorothalonil 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25cymoxanil 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 cyproconazole 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 cyprodinil 625:1 to 1:625 125:1 to1:125 25:1 to 1:25 cyazofamid 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25difenoconazole 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 dimoxystrobin625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 epoxiconazole 625:1 to 1:625125:1 to 1:125 25:1 to 1:25 fenpropidin 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 ferimzone 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25fluazinam 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 fludioxonil 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 flutolanil 625:1 to 1:625 125:1 to1:125 25:1 to 1:25 Flutriafol 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25fluxapyroxad 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 gentamycin 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 hymexazol 625:1 to 1:625 125:1 to1:125 25:1 to 1:25 imazalil 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25ipconazole 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 isoprothiolane625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 isopyrazam 625:1 to 1:625125:1 to 1:125 25:1 to 1:25 kasugamycin 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 mancozeb 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25mandipropamid 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 maneb 625:1 to1:625 125:1 to 1:125 25:1 to 1:25 mefenoxam 625:1 to 1:625 125:1 to1:125 25:1 to 1:25 metalaxyl 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25metconazole 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 metrafenone 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 orysastrobin 625:1 to 1:625 125:1to 1:125 25:1 to 1:25 penthiopyrad 625:1 to 1:625 125:1 to 1:125 25:1 to1:25 picoxystrobin 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25probenazole 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 propiconazole625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 proquinazid 625:1 to 1:625125:1 to 1:125 25:1 to 1:25 pyraclostrobin 625:1 to 1:625 125:1 to 1:12525:1 to 1:25 pyrimethanil 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25pyroquilon 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 quinoxyfen 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 sedaxane 625:1 to 1:625 125:1 to1:125 25:1 to 1:25 tetraconazole 625:1 to 1:625 125:1 to 1:125 25:1 to1:25 thiophanate-methyl 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25thiram 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25 tolclofos-methyl 625:1to 1:625 125:1 to 1:125 25:1 to 1:25 tricyclazole 625:1 to 1:625 125:1to 1:125 25:1 to 1:25 triticonazole 625:1 to 1:625 125:1 to 1:125 25:1to 1:25 validamycin 625:1 to 1:625 125:1 to 1:125 25:1 to 1:25

When using the active compound combinations according to the inventionas fungicides, insecticides or acaricides, the application rates can bevaried within a relatively wide range, depending on the kind ofapplication. The application rate of the active compound combinationsaccording to the invention is when treating plant parts, e.g. leaves:from 0.1 to 1000 g/ha, preferably from 10 to 500 g/ha, particularlypreferably from 50 to 300 g/ha (when the application is carried out bywatering or dripping, it may even be possible to reduce the applicationrate, in particular when inert substrates such as rock wool or perliteare used); when treating seed: from 1 to 2000 g per 100 kg of seed,preferably from 2 to 1000 g per 100 kg of seed, particularly preferablyfrom 3 to 750 g per 100 kg of seed, very particularly preferably from 5to 500 g per 100 kg of seed; when treating the soil: from 0.1 to 5000g/ha, preferably from 1 to 1000 g/ha.

These application rates are mentioned only by way of example and are notlimiting the sense of the invention.

The active compound combinations according to the invention can beemployed for protecting plants for a certain period of time aftertreatment against attack by phytopathogenic fungi and/or animal pests.The period for which protection is provided extends generally for 1 to28 days, preferably for 1 to 14 days, particularly preferably for 1 to10 days, very particularly preferably for 1 to 7 days after thetreatment of the plants with the active compounds, or for up to 200 daysafter a seed treatment.

The active compound combinations according to the invention, incombination with good plant tolerance and favourable toxicity towarm-blooded animals and being tolerated well by the environment, aresuitable for protecting plants and plant organs, for increasing theharvest yields, for improving the quality of the harvested material andfor controlling phytopathogenic fungi such as Plasmodiophoromycetes,Oomycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes,Deuteromycetes etc. and animal pests, in particular insects, arachnids,helminths, nematodes and molluscs, which are encountered in agriculture,in horticulture, in animal husbandry, in forests, in gardens and leisurefacilities, in the protection of stored products and of materials, andin the hygiene sector. They can preferably be used as crop protectioncompositions. They are active against normally sensitive and resistantspecies and against all or some stages of development.

The active compound combinations according to the invention have a verygood fungicidal activity and can be employed for controllingphytopathogenic fungi such as Plasmodiophoromyeetes, Oomycetes,Chytridiontycetes, Zygomycetes, Ascomycetes, Basidiomycetes,Deuteromycetes and the like.

The active compound combinations according to the invention areparticularly suitable for controlling Phytophthora infestans, Plasmoparaviticola and Botrytis cinerea.

Some pathogens causing fungal and bacterial diseases which con er thegeneric names listed above may be mentioned as examples, but not by wayof limitation:

Fungicides can be employed in crop protection for controllingPlasmodiophoromycetes, Oomycetes, Chytridiornycetes, Zygomycetes,Ascomycetes, Basidiomycetes and Deuteromycetes.

Bactericides can be employed in crop protection for controllingPseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceaeand Streptomycetaceae.

Some pathogens causing fungal and bacterial diseases which come underthe generic names listed above may be mentioned as examples, but not byway of limitation:

diseases caused by powdery mildew pathogens, such as, for example,

Blumeria species, such as, for example, Blurneria graminis;

Podosphaera species, for example Podosphaera leucotricha;

Sphaerotheca species, for example Sphaerotheca fuliginea;

Uncinula species, such as, for example, Uncinula necator;

diseases caused by rust disease pathogens, such as, for example,

Gymnosporangium species, such as, for example, Gymnosporangium sabinae

Hemileia species, such s for example Hemileia vastatrix,

Phakopsora species, such as, for example, Phakopsora pachyrhizi andPhakopsora meibomiae;

Puccinia species, for example Puccinia recondita;

Uromyces species, for example Uromyces appendiculatus

diseases caused by pathogens from the group of the Oomycetes, such as,for example,

Bremia species, for example Bremia lactucae;

Peronospora species, for example Peronospora pisi or P. brassicae;

Phytophthora species, for example Phytophthora infestans;

Plasmopara species, for example Plasmopara viticola;

Pseudoperonospora species, for example Pseudoperonospora humuli or

Pseudoperonospora cubensis;

Pythium species, for example Pythium ultimum;

leaf blotch diseases and leaf wilt diseases caused, for example, by

Alternaria species, such as, for example, Alternaria solani;

Cercospora species, such as, for example, Cercospora beticola;

Cladiosporum species, such as, for example, Cladiosporium cucumerinum;

Cochliobolus species, such as, for example, Cochliobolus sativus;

(conidia form: Drechslera, syn: Helminthosporium);

Colletotrichum species, such as, for example, Colletotrichumlindemuthanium;

Cycloconium species, such as, for example, Cycloconium oleaginum;

Diaporthe species, such as, for example, Diaporthe citri;

Eisinoe species, such as, for example, Elsinoe fawcettii;

Gloeosporium species, such as, for example, Gloeosporium laeticolor;

Glomerella species, such as, for example, Glomerella cingulata;

Guignardia species, such as, for example, Guignardia bidwelli;

Leptosphaeria species, such as, for example, Leptosphaeria maculans;

Magnaporthe species, such as, for example, Magnaporthe grisea;

Mycosphaerella species, such as, for example, Mycosphaerellegraminicola;

Phaeosphaeria species, such as, for example, Phaeosphaeria nodorum;

Pyrenophora species, such as, for example, Pyrenophora teres;

Ramularia species, such as, for example, Ramularia collo-cygni;

Rhynchosporium species, such as, for example, Rhynchosporium secalis;

Septoria species, such as, for example, Septoria apii;

Typhula species, such as, for example, Typhula incarnata;

Venturia species, for example Venturia inaequalis;

root and stein diseases caused, for example, by

Corticium species, such as, for example, Corticium graminearum;

Fusarium species, such as, for example, Fusarium oxysporum;

Gaeumannomyces species, such as, for example, Gaeumannomyces graminis;

Rhizoctonia species, such as, for example, Rhizoctonia solani;

Tapesia species, such as, for example, Tapesia acuformis;

Thielaviopsis species, such as, for example, Thielaviopsis basicola;

ear and panicle diseases (including maize cobs) caused, for example, by

Altenaria species, such as, for example, Alternaria spp.;

Aspergillus species, such as, for example, Aspergillus flavus;

Cladosporium species, such as, for example, Cladosporium spp.;

Claviceps species, such as, for example, Claviceps purpurea;

Fusarium species, for example Fusarium culmorum;

Gibberella species, such as, for example, Gibberella zeae;

Monographella species, such as, for example, Monographella nivalis;

diseases caused by smut fungi, such as, for example,

Sphacelotheca species, such as, for example, Sphacelotheca reiliana;

Tilletia species, for example Tilletia caries;

Urocystis species, such as, for example, Urocystis occulta;

Ustilago species such as, for example, Ustilago nuda;

fruit rot caused, for example, by

Aspergillus species, such as, for example, Aspergillus flavus;

Botrytis species, for example Botrytis cinerea;

Penicillium species, such as, for example, Penicillium expansum;

Sclerotinia species, for example Sclerotinia sclerotiorum;

Verticilium species, such as, for example, Verticilium alboatrum;

seed- and soil-borne rot and wilt diseases, and also diseases ofseedlings, caused, for example, by

Fusarium species, for example Fusarium culmorum;

Phytophthora species, such as, for example, Phytophthora cactorum;

Pythium species, for example Pythium ultimum;

Rhizoctonia species, such as, for example, Rhizoctonia solani;

Selerotium species, such as, for example, Selerotium rolfsii;

cancerous diseases, galls and witches' broom caused, for example, by

Nectria species, such as, for example, Nectria galligena;

wilt diseases caused, for example, by

Monilinia species, such as, for example, Monilinia laxa;

deformations of leaves, flowers and fruits caused, for example, by

Taphrina species, such as, for example, Taphrina deformans;

degenerative diseases of woody plants caused, for example, by

Esca species, such as, for example, Phaemoniella clamydospora;

diseases of flowers and seeds caused, for example, by

Botrytis species, for example Botrytis cinerea;

diseases of plant tubers caused, for example, by

Rhizoctonia species, such as, for example, Rhizoctonia solani;

diseases caused by bacterial pathogens, such as, for example,

Xanthomonas species, for example Xanthomonas campestris pv. oryzae;

Pseudomonas species, for example Pseudomonas syringae pv. lachrymans;

Erwinia species, such as, for example, Erwinia amylovora.

Preference is given to controlling the following diseases of soya beans:

fungal diseases on leaves, sterns, pods and seeds caused, for example,by

artemaria leaf spot (Alternaria spec. atrans tenuissima), anthracnose(Colletotrichum gioeosporoides dematium var. truncatum), brown spot(Septoria glycines), cercospora leaf spot and blight (Cercosporakikuchii), choanephora leaf blight (Choanephora infundibulifera trispora(Syn.)), dactuliophora leaf spot (Dactuliophora glycines), downy mildew(Peronospora manshurica), drechslera blight (Drechslera glycini) frogeyeleaf spot (Cercospora sojina), leptosphaerulina leaf spot(Leptosphaerulina trifoiii), phyllostica leaf spot (Phyllostictasojaecola), powdery mildew (Microsphaera diffusa), pyrenochaeta leafspot (Pyrenochaeta glycines), rhizoctonia aerial, foliage, and webblight (Rhizoctonia solani), rust (Phakopsora pachyrhizi), scab(Sphaceloma glycines), stemphylium leaf blight (Stemphylium botryosum),target spot (Corynespora cassiicola).

Fungal diseases on roots and the stem base caused, for example, by

black root rot Calonectria crotalariae), charcoal rot (Macrophominaphaseolina), fusarium blight or wilt, root rot, and pod and collar rot(Fusarium oxysporum, Fusarium orthoceras Fusarium semitectum, Fusariumequiseti), mycoleptodiscus root rot (Tvlycoleptodiscus terrestris),neocosmospora (Neocosmospora vasinfecta), pod and stem blight (Diaporthephaseolorum), stem canker (Diaporthe phaseolorum var. caulivora),phytophthora rot (Phytophthora megasperma), brown stem rot (Phialophoragregata), pythium rot (Pythium aphanidermaturn, Pythium irregulare,Pythium debaryanum, Pythium myriotylum, Pythium ultimum), rhizoctoniaroot rot, stem decay, and damping-off (Rhizoctonia solani), sclerotiniastem decay (Sclerotinia sclerotiorum) sclerotinia southern blight(Sclerotinia rolfsii), thielaviopsis root rot (Thielaviopsis basicola).

The active compound combinations according to the invention can beemployed particularly successfully for controlling cereal diseases suchas, for example, against Puccinia species and diseases in viticultureand fruit and vegetable growing such as, for example, against Botrytis,Venturia or Altemaria species.

In addition, the active compound combinations according to the inventionalso have very good antimycotic activity. They have a very broadantimycotic activity spectrum, in particular against dermatophytes andyeasts, moulds and diphasic fungi, (for example against Candida species,such as Candida albicans, Candida glabrata), and Epidermophytonfloccosum, Aspergillus species, such as Aspergilius niger andAspergillus fumigatus, Trichophyton species, such as Trichophytonmentagrophytes, Microsporon species such as Microsporon canis andaudohinii. The list of these fungi by no means constitutes a restrictionof the mycotic spectrum covered, and is merely of illustrativecharacter.

In addition, the active compound combinations according to the inventionalso have very good insecticidal activity. They have a very broadspectrum of insecticidal activity, in particular against the followinganimal pests:

From the order of the Anoplura (Phthiraptera), for example, Damaliniaspp., Haematopinus spp., Linognathus spp., Pediculus spp., Trichodectesspp.

From the class of the Arachnida, for example, Acarus spp., Aceriasheldoni, Aculops spp., Aculus spp., Amblyomma spp., Amphitetranychusviennensis, Argas spp., Boophilus spp., Brevipalpus spp., Bryobiapraetiosa, Chorioptes spp., Dermanyssus gallinae, Eotetranychus spp.,Epitrimerus pyri, Eutetranychus spp., Eriophyes spp., Halotydeusdestructor, Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Latrodectusmactans, Metatetranychus spp Nuphersa spp., Oligonychus spp.,Ornithodoros spp., Panonychus spp., Phyllocoptruta oleivora,Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp.,Rhizoglyphus spp., Sarcoptes spp., Scorpio maurus, Stenotarsonemus spp.,Tarsonemus spp., Tetranychus spp., Vasates lycopersici.

From the class of the Bivalva, for example, Dreissena spp.

From the order of the Chilopoda, for example, Geophilus spp., Scutigeraspp.

From the order of the Coleoptera, for example Acalymma vittatum,Acanthoscelides obtectus, Adoretus spp., Agelastica aini, Agriotes spp.,Amphimallon solstitialis, Anobium punctatum, Anoplophora spp.,Anthonomus spp., Anthrenus spp., Apion spp., Apogonia spp., Atomariaspp., Attagerms spp., Bruchidius obtectus, Bruchus spp., Cassida spp.,Cerototma trifurcata, Ceutorrhynchus spp., Chaetocnema spp., Cleonusmendicus, Conoderus spp., Cosmopolites spp., Costelytra zealandica,Ctenicera spp., Curcolio spp., Cryptorhynchus lapathi, Cylindrocopturusspp., Dermestes spp., Diabrotica spp., Dichocrocis spp., Diloboderusspp., Epilachna spp., Epitrix spp., Faustinus spp., Gibbium psylloides,Hellula undalis, Heteronychus arator, Heteronyx spp., Hylamorphaelegans, Hylotrupes bajulus, Hypera postica, Hypothenemus spp.,Lachnosterna consannguinea, Lema spp., Leptinotarsa decemlineata,Leucoptera spp., Lissorhoptrus oryzophilus, Lixus spp., Luperodes spp.,Lyctus spp., Megascelis spp., Melelanotus spp., Meligethes aeneus,Melolontha spp., Migdoles spp., Monochamus spp., Naupactusxanthographus, Niptus hololeucus, Oryctes rhinoceros, Oryzaephilussurinamensis, Oryzaphagus olyzae, Otiorrhynchus spp., Oxycetoniajucunda, Phaedon cochleariae, Phyllophaga spp., Phyllotreta spp.,Popillia japonica, Premnotrypes spp., Psylliodes spp., Ptinus spp.,Rhizobius ventralis, Rhizopertha dominica, Sitophilus spp., Sphenophorusspp., Sternechus spp., Symphyletes spp., Tanymecus spp., Tenebriomolitor, Tribolium spp., Trogoderma spp., Tychius spp., Xylotrechusspp., Zabrus spp.

From the order of the Collembola, for example, Onychiurus annatus.

From the order of the Diplopoda, for example, Blaniulus guttulatus.

From the order of the Diptera, for example, Aedes spp., Agromyza spp.,Anastrepha spp., Anopheles spp., Asphondylia spp., Bactrocera spp.,Bibio hortulanus, Calliphora crythrocephala, Ceratitis capitata,Chironomus spp., Chrysomyia spp., Cochliomyia spp., Contarinia spp.,Cordylobia anthropophaga, Culex spp., Cuterebra spp., Dacus oleae,Dasyneura spp., Delia spp., Dermatobia hominis Drosophila spp.,Echinocnemus spp., Fannia spp., Gastrophilus spp., Hydrellia spp.,Hylemyia spp., Hyppobosca spp., Hypoderma spp., Liriomyza spp., Luciliaspp., Musca spp., Nezara spp., Oestrus spp., Oscinella frit, Pegomyiaspp., Phorbia spp., Prodiplosis spp., Psila rosae, Rhagoletis spp.,Stornoxys spp., Tabanus spp., Tannia spp., Tetanops spp., Tipula spp.

From the class of the Gastropoda, for example, Anion spp., Biomphalariaspp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp.,Oncomelania spp., Pomacea spp., Succinea spp.

From the class of the helminths, for example, Ancylostoma duodenale,Ancylostoma ceylanicum, Akcylostoma braziliensis, Ancylostoma spp.,Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia timori,Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp.,Dicrocoelium spp, Dictyocaulus filaria, Diphyllobothrium latum,Dracunculus medinensis, Echinococcus granulosus, Echinococcusmultilocularis, Enterobius vermicularis, Faciola spp., Haemonchus spp.,Heterakis spp., Hymenolepis nana, Hyostrongulus spp., Loa Loa,Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocercavolvulus, Ostertagia spp., Paragonimus spp., Schistosomen spp.,Strongyloides fuelleborni, Strongyloides stercoralis, Stronyloides spp.,Taenia saginata, Taenia solium, Trichinella spiralis, Trichinellanativa, Trichinella britovi, Trichinella nelsoni, Trichinellapseudopsiralis, Trichostrongulus spp., Trichuris trichina, Wuchereriabancrofti.

It is furthermore possible to control protozoa, such as Eimeria.

From the order of the Heteroptera, for example, Anasa tristis,Antestiopsis spp., Blissus spp., Calocoris spp., Campylomina livida,Cavelerius spp., Cimex spp., Collaria spp., Creontiades dilutus, Dasynuspiperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp.,Euschistus spp., Eurygaster spp., Heliopeltis spp., Horcias nobilellus,Leptocorisa spp., Leptoglossus phyllopus, Lygus spp., Macropesexcavatus, Miridae, Monalonion atratum, Nezara spp., Oebalus spp.,Pentomidae, Piesma quadrata, Piezodorus spp., Psallus spp., Pseudacystapersea, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanca,Scotinophora spp., Stephanitis nashi, Tibraca spp., Triatoma spp.

From the order of noptera, for example, Acyrthosipon spp., Acrogoniaspp., Aeneolamia spp., Agonoscena spp., Aleurodes spp., Aleurolobusbarodensis, Aleurothrixus spp., Amrasca spp., Anuraphis cardui,Aonidiella spp., Aphanostigma piri, Aphis spp., Arboridia apicalis,Aspidiella spp., Aspidiotus spp., Atanus spp., Autlacorthum solani,Bemisia spp., Brachycaudus helichrysii, Brachycolus spp., Brevicorynebrassicae, Calligypona marginata, Carneocephala fulgida, Ceratovacunalanigera, Cercopidae, Ceroplastes spp., Chaetosiphon fragaefolii,Chionaspis tegalensis, Chlorita onukii, Chromaphis juglandicola,Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus spp.,Cryptomyzus ribis, Dalbulus spp., Dialeurodes spp., Diaphorina spp.,Diaspis spp., Drosicha spp., Dysaphis spp Dysmicoccus spp., Empoascaspp., Eriosoma spp., Erythroneura spp., Euscelis bilobatus, Ferrisiaspp., Geococcus coffeae, Hieroglyphus spp., Homalodisca coagula,Hyalopterus arundinis, Icerya spp., Idiocerus spp., Idioscopus spp.,Laodelphax striatellus, Lecanium spp., Lepidosaphes spp., Lipaphiserysimi, Macrosiphum spp., Mahanarva spp., Melanaphis sacchari,Metcalfiella spp., Metopolophium dirhodum, Monellia costalis,Monelliopsis pecanis, Myzus spp., Nasonovia ribisnigri, Nephotettixspp., Nilaparvata lugens, Oncometopia spp., Orthezia praelonga,Parabemisia myricae, Paratrioza spp., Parlatoria spp., Pemphigus spp.,Peregrinus maidis, Phenacoccus spp., Phloeomyzus passerinii, Phorodonhamuli, Phylloxera spp., Pinnaspis aspidistrae, Planococcus spp.,Protopulvinaria pyriformis, Pseudaulacaspis pentagona, Pseudococcusspp., Psylla spp., Pteromalus spp., Pyrilla spp., Quadraspidiotus spp.,Quesada gigas, Rastrococcus spp., Rhopalosiphum spp., Saissetia spp.,Scaphoides titanus, Schizaphis graminum, Selenaspidus articulatus,Sogata spp., Sogatella furcifera, Sogatodes spp., Stictocephala festina,Tenalaphara malayensis, Tinocallis caryaefoliae, Tomaspis spp.,Toxoptera spp., Trialeurodes spp., Trioza spp., Typhkocyba spp., Unaspisspp., Viteus vitifolii, Zygina spp.

From the order of the Hymenoptera, for example, Athalia spp., Diprionspp., Hoplocampa spp., Lasius spp., Monomorium pharaonis, Vespa spp.

From the order of the Isopoda, for example, Armadillidium vulgare,Oniscus asellus and Porcellio scaber.

From the order of the Isoptera, for example, Acromyrmex spp., Atta spp.,Cornitermes cumulans, Microtermes obesi, Odontotermes spp.,Reticulitermes spp.

From the order of the Lepidoptera, for example, Acronicta major,Adoxophyes spp., Aedia leucomelas, Agrotis spp., Alabama spp., Amyeloistransitella, Anarsia spp., Anticasia spp., Argyroploce spp.,Barathrabrassicae, Borbo cinnara, Bucculatrix thurberiella, Bupalus piniarius,Busseola spp., Cacoecia spp., Caloptilia theivora, Capua reticulana,Carpocapsa pomonella, Carposina niponensis, Cheimatobia brumata, Chilospp., Choristoneura spp., Clysia ambiguella, Cnaphalocerus spp.,Cnephasia spp., Conopomorpha spp., Conotrachelus spp., Copitarsia spp.,Cydia spp., Dalaca noctuides, Diaphania spp., Diatraea saccharalis,Earias spp, Ecdytolopha aurantium, Elasmopalpus lignosellus, Eldanasaccharina, Ephestia kuehniella, Epinotia spp., Epiphyas postvittana,Etiella spp., Eulia spp., Eupoecilia ambiguella, Euproctis spp., Euxoaspp., Feltia spp., Galleria mellonella, Gracillaria spp., Grapholithaspp., Hedylepta spp., Helicoverpa spp., Helothis spp., Hofinannophilapseudospretella, Homoeosoma spp, Homona spp., Hyponomeuta padella,Kakivoria flavofasciata, Laphygma spp., Laspeyresia molesta, Leucinodesorbonalis, Leucoptera spp., Lithocolletis spp., Lithophane antennata,Lobesia spp., Loxagrotis albicosta, Lymantria spp., Lyonetia spp.,Malacosoma neustria, Maruca testulalis, Mamestra brassicae, Mocis spp.,Mythimna separata, Nymphula spp., Oiketicus spp., Oria spp., Orthagaspp., Ostrinia spp., Oulema oryzae, Panolis flammea, Parnara spp.,Pectinophora spp., Perileucoptera spp., Phthorimaea spp., Phyllocnistiscitrella, Phyllonorycter spp., Pieris spp., Platynota stultana, Plusiaspp., Plutella xylostella, Prays spp, Prodenia spp., Protoparce spp.,Pseudaletia spp., Pseudoplusia includens, Pyrausta nubilalis,Rachiplusia nu, Schoenobius spp., Scirpophaga spp., Scotia segetum,Sesamia spp., Sparganothis spp., Spodoptera spp., Stathmopoda spp.,Stornopteryx subsecivella, Synanthedon spp., Tecia solanivora, Thermesiagemmatalis, Tinea pellionella, Tineola bisselliella, Tortrix spp.,Trichoplusia spp., Tuta absoluta, Virachola spp.

From the order of the Orthoptera, for example, Acheta domesticus, Blattaorientalis, Blattella gerrnanica, Dichroplus spp., Gryllotalpa spp.,Leucophae maderae, Locusta spp., Melanoplus spp., Periplaneta americana,Schistocerca gyegaria.

From the order of the Siphonaptera, for example, Ceratophyllus spp. andXenopsylla cheopis.

From the order of the Symphyla, for example, Scutigerella spp.

From the order of the Thysanoptera, for example Anaphothrips obscurus,Baliothrips biformis, Drepanothris reuteri, Enneothrips flavens,Frankliniella spp., Heliothrips spp., Hercinothrips femoralis,Rhipiphorothrips cruentatus, Scirtothrips spp., Taeniothrips cardamoni,Thrips spp.

From the order of the Thysanura, for example, Lepisma saccharina.

The phytoparasitic nematodes include, for example, Aphelenchoides spp.,Bursaphelenchus spp., Ditylenchus spp., Globodera spp., Heterodera spp.,Longidorus spp., Meloidogyne spp., Pratylenchus spp., Radopholussimilis, Trichodorus spp., Tylenchulus semipenetrans, Xiphinema spp.

In the protection of materials, the active compound combinationsaccording to the invention can be employed for protecting industrialmaterials against infection with, and destruction by, undesiredmicroorganisms.

Industrial materials in the present context are understood to meaninanimate materials which have been prepared for use in industry. Forexample, industrial materials which are to be protected by inventiveactive compounds from microbial alteration or destruction may beadhesives, sizes, paper and cardboard, textiles, leather, wood, paintsand plastic articles, cooling lubricants and other materials which canbe infected with or destroyed by microorganisms. The range of materialsto be protected also includes parts of production plants, for examplecooling water circuits, which may be impaired by the proliferation ofmicroorganisms. Industrial materials within the scope of the presentinvention preferably include adhesives, sizes, papers and cardboard,leather, wood, paints, cooling lubricants and heat transfer fluids, morepreferably wood.

Microorganisms capable of degrading or altering the industrial materialsinclude, for example, bacteria, fungi, yeasts, algae and slimeorganisms. The active compound combinations according to the inventionpreferably act against fungi, in particular moulds, wood-discolouringand wood-destroying fungi (Basidiomycetes), and against slime organismsand algae.

Examples include microorganisms of the following genera:

Alternaria such as Alternaria tenuis,

Aspergillus such as Aspergillus niger,

Chaetomium such as Chaetomium globostan,

Coniophora such as Coniophora puetana,

Lentinus such as Lentinus tigrinus,

Penicillium such as Penicillium glaucum,

Polyporus such as Polyporus versicolor,

Aureobasidium such as Aureobasidium pullulans,

Sclerophoma such as Sclerophoma pityophila,

Trichoderma such as Trichoderma viride,

Escherichia such as Escherichia coli,

Pseudomonas such as Pseudomonas aeruginosa, and

Staphylococcus such as Staphylococcus aureus.

Moreover, it has been found that the active compound combinationsaccording to the invention show a potent insecticidal action againstinsects which destroy industrial materials.

Preferred but nonlimiting examples include the following insects:

beetles, such as Hylotrupes bajulus, Chlorophorus pilosis, Anobiumpunctatum, Xestobium rufovillosum, Ptilinus pecticornis, Dendrobiumpertinex, Emobilis mollis, Priobium carpini, Lyctus brunneus, Lyctusafficanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens,Trogoxylon aequale, Minthes rugicollis, Xyleborus spec. Tryptodendronspec. Apate monachus, Bostrychus capucins, Heterobostrychus brunneus,Sinoxylon spec. Dinoderus mimsrus.

Dermapterans, such as Sirex juvencus, Urocerus gigas, Urocerus gigastaignus, Urocerus augur.

Termites, such as Kalotermes flavicollis, Cryptotermes brevis,Heterotemes indicola, Reticulitermes flavipes, Reticulitermessantonensis, Reticulitermes lucifugus, Mastotermes darwiniensis,Zootermopsis nevadensis, Coptotermes formosanus.

bristletails, such as Lepisma saccarina.

Industrial materials in the present connection are understood to meaninanimate materials, such as preferably plastics, adhesives, sizes,papers and cards, leather, wood, processed wood products and coatingcompositions.

Most preferably, the material to be protected from insect infestationcomprises wood and processed wood products.

Wood and processed wood products which can be protected by the activecompound combinations according to the invention are to be understood asmeaning, for example: building timber, wooden beams, railway sleepers,bridge components, boat jetties, wooden vehicles, boxes, pallets,containers, telegraph poles, wood panelling, wooden windows and doors,ltxywood, chipboard, joinery or wooden products which are used quitegenerally in house-building or in building joinery.

The active compound combinations can be used as such, in the foil ofconcentrates or generally customary formulations such as powders,granules, solutions, suspensions, emulsions or pastes.

The formulations mentioned can be prepared in a manner known per se, forexample by mixing the active compounds with at least one solvent ordiluent, emulsifier, dispersing agent and/or binder or fixing agent, awater repellent, if appropriate siccatives and UV stabilizers and ifappropriate dyestuffs and pigments, and also other processingauxiliaries.

The insecticidal active compound combinations or concentrates used forthe preservation of wood and wood-derived timber products comprise theactive compound according to the invention in a concentration of 0.0001to 95% by weight, in particular 0.001 to 60% by weight.

The amount of the active compound combinations or concentrates employeddepends on the nature and occurrence of the insects and on the medium.The optimum amount employed can be determined for the use in each caseby a series of tests. In general, however, it is sufficient to employ0.0001 to 20% by weight, preferably 0.001 to 10% by weight, of theactive compound, based on the material to be preserved.

The active compound combinations are also suitable for controllinganimal pests, especially insects, arachnids and mites, which areencountered in enclosed spaces, for example dwellings, factory hulls,offices, vehicle cabins and the like. They can be used in domesticinsecticide products for controlling these pests. They are effectiveagainst sensitive and resistant species, and against all developmentalstages. These pests include:

From the order of the Scorpionidea, for example, Buthus occitanus.

From the order of the Acarina, for example, Argas persicus, Argasreflexus, Bryobia spp., Dermanyssus gallinae, Glyciphagus domesticus,Ornithodorus moubat, Rhipicephalus sanguineus, Trombicula alfreddugesi,Neutrombicula autumnalis, Dermatophagoides pteronissimus,Dermatophagoides forinae.

From the order of the Aranae, for example, Aviculariidae, Araneidae.

From the order of the Opiliones, for example, Pseudoscorpiones chelifer,Pseudoscorpiones cheiridium, Opiliones phalangium.

From the order of the Isopoda, for example, Oniscus asellus, Porcellioscaber.

From the order of the Diplopoda, for example, Blaniulus guttulatus,Polydesmus spp.

From the order of the Chilopoda, for example, Geophilus spp.

From the order of the Zygentoma, for example, Ctenolepisma spp., Lepismasaccharina, Lepismodes inquilinus.

From the order of the Blattaria, for example, Blatta orientalies,Blattella germanica, Blattella asahinai, Leucophaea maderae, Panchloraspp., Parcoblatta spp., Periplaneta australasiae, Periplaneta americana,Periplaneta brunnea, Periplaneta fuliginosa, Supella longipalpa.

From the order of the Saltatoria, for example, Acheta domesticus.

From the order of the Isopiera, for example, Kalotermes spp.,Reticulitermes spp.

From the order of the Psocoptera, for example, Lepinatus spp.,Liposcelis spp.

From the order of the Coleoptera, for example, Anthrenus spp., Attagenusspp., Dermestes spp., Latheticus oryzae, Necrobia spp., Ptinus spp.,Rhizopertha dominica, Sitophilus granarius, Sitophilus oryzae,Sitophilus zeamais, Stegobium paniceurn.

From the order of the Diptera, for example, Aedes aegypti, Aedesalbopictus, Aedes taeniorhynchus, Anopheles spp., Calliphoraerythrocephala, Chrysozona pluvialis, Culex quinquefasciatus, Culexpipiens, Culex tarsalis, Drosophila spp., Fannia canicularis, Muscadomestica, Phlebotomus spp., Sarcophaga carnaria, Simulium spp.,Stomoxys calcitrans, Tipula paludosa.

From the order of the Lepidoptera, for example, Achroia grisella,Galleria mellonella, Plodia interpunctella Tinea cloacella, Tineapellionella, Tineola bisselliella.

From the order of the Siphonaptera, for example, Ctenocephalides canis,Ctenocephalides felis, Pulex irritans, Tunga penetrans, Xenopsyllacheopis.

From the order of the Hymenoptera, for example, Camponotus herculeanus,Lasius fuliginosus, Lasius niger, Lasius umbratus, Monomorium pharaonis,Paravespula spp., Tetramorium caespitum.

From the order of the Anoplura, for example, Pediculus humanus capitis,Pediculus humanus corporis, Phthirus pubis.

From the order of the Heteroptera, for example, Cimex hemipterus, Cimexlectularius, Rhodinus prolixus, Triatoma infestans.

They are used in aerosols, pressure-free spray products, for examplepump and atomizer sprays, automatic fogging systems, foggers, foams,gels, evaporator products with evaporator tablets made of cellulose orplastic, liquid evaporators, gel and membrane evaporators,propeller-driven evaporators, energy-free, or passive, evaporationsystems, moth papers, moth bags and moth gels, as granules or dusts, inbaits for spreading or in bait stations.

The active compound combinations according to the invention are not onlyactive against plant pests, hygiene pests and stored-product pests, butalso in the veterinary medicine sector, against animal parasites(ectoparasites) such as hard ticks, soft ticks, mange mites, harvestmites, flies (stinging and licking), parasitizing fly larvae, lice, hairlice, bird lice and fleas. These parasites include:

From the order of the Anoplurida, for example, Haematopinus spp,Linognathus spp., Pediculus spp., Phtirus spp. and Solenopotes spp.

From the order of the Mallophagida and the suborders Amblycerina andIschnocerina, for example, Trimenopon spp., Menopon spp., Trinoton spp.,Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp.,Trichodectes spp. and Felicola spp.

From the order of the Diptera and the suborders Nematocerina andBrachycerina, for example, Aedes spp., Anopheles spp., Culex spp.,Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp.,Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanusspp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp.,Hydrotaea spp., Stomoxys spp, Haematobia spp., Morellia spp., Fanniaspp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp.,Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp.,Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp.

From the order of the Siphonapterida, for example Pulex spp.,Ctenocephalides spp., Xenopsylla spp. and Ceratophyllus spp.

From the order of the Heteropterida, for example, Cimex spp., Triatomaspp., Rhodnius spp. and Panstrongylis spp.

From the order of the Blattarida, for example Blatta orientails,Periplaneta americana, Blattela germanica and Supella spp.

From the subclass of the Acaria (Acarida) and the orders of the Meta-and Mesostigmata, for example Argas spp., Ornithodorus spp., Otobiusspp, Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp.,Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp.,Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp.

From the order of the Actinedida (Prostigmata) and Acaridida(Astigmata), for example, Acarapis spp., Cheyletiella spp.,Omithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp.,Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp.,Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp.,Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp.,Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.

The active compound combinations according to the invention are alsosuitable for controlling arthropods which attack agricultural livestocksuch as, for example, cattle, sheep, goats, horses, pigs, donkeys,camels, buffaloes, rabbits, chickens, turkeys, ducks, geese, honey-bees,other domestic animals such as, for example, dogs, cats, caged birds,aquarium fish and so-called experimental animals such as, for example,hamsters, guinea pigs, rats and mice. The control of these arthropods isintended to reduce cases of death and reduced productivity (of meat,milk, wool, hides, eggs, honey etc.), and so more economic and easieranimal husbandry is possible by use of the active compound combinationsaccording to the invention.

The active compound combinations according to the invention are used inthe veterinary sector in a known manner by enteral administration in theform of, for example, tablets, capsules, potions, drenches, granules,pastes, boluses, the feed-through process and suppositories, byparenteral administration, such as, for example, by injection(intramuscular, subcutaneous, intravenous, intraperitoncal and thelike), implants, by nasal administration, by dermal use in the form, forexample, of dipping or bathing, spraying, pouring on and spotting on,washing and powdering, and also with the aid of moulded articlescontaining the active compound, such as collars, ear marks, tail marks,limb bands, halters, marking devices and the like.

When used for cattle, poultry, domestic animals and the like, the activecompound combinations can be applied as foimulations (for examplepowders, emulsions, flowables) comprising the active compounds in anamount of 1 to 80% by weight, either directly or after 100- to 10000-fold dilution, or they may be used as a chemical dip.

If appropriate, the active compound combinations according to theinvention can, at certain concentrations or application rates, also beused as herbicides, safeners, growth regulators or agents to improveplant properties, or as microbicides, for example as fungicides,antimycotics, bactericides, viricides (including agents against viroids)or as agents against MLO (Mycoplasma-like organisms) and RLO(Rickettsia-like organisms).

The present invention further relates to formulations and use formsprepared therefrom as crop protection compositions and/or pesticides,for example drench, drip and spray liquors, comprising at least one ofthe active compound combinations according to the invention. In somecases, the use forms comprise further crop protection compositionsand/or pesticides and/or adjuvants which improve action, such aspenetrants, e.g. vegetable oils, for example rapeseed oil, sunfloweroil, mineral oils, for example paraffin oils, alkyl esters of vegetablefatty acids, for example rapeseed oil methyl ester or soya oil methylester, or alkanol alkoxylates and/or spreaders, for examplealkyisiloxanes and/or salts, for example organic or inorganic ammoniumor phosphonium salts, for example ammonium sulphate or diammoniumhydrogenphosphate and/or retention promoters, for example dioetylsulphosuccinate or hydroxypropyl guar polymers and/or humectants, forexample glycerol and/or fertilizers, for example ammonium-, potassium-or phosphorus-containing fertilizers.

Customary formulations are, for example, water-soluble liquids (SL),emulsion concentrates (EC), emulsions in water (EW), suspensionconcentrates (SC, SE, FS, OD), water-dispersible granules (WG), granules(GR) and capsule concentrates (CS); these and further possibleformulation types are described, for example, by Crop Life Internationaland in Pesticide Specifications, Manual on development and use of FAOand WHO specifications for pesticides, FAO Plant Production andProtection Papers-173, prepared by the FAO/WHO Joint Meeting onPesticide Specifications, 2004, ISBN: 9251048576. The formulationsoptionally comprise, in addition to one or more active compoundsaccording to the invention, further agrochemically active compounds.

These are preferably formulations or use forms which compriseauxiliaries, for example extenders, solvents, spontaneity promoters,carriers, emulsifiers, dispersants, frost protectants, biocides,thickeners and/or further auxiliaries, for example adjuvants. Anadjuvant in this context is a component which enhances the biologicaleffect of the formulation, without the component itself having abiological effect. Examples of adjuvants are agents which promoteretention, spreading, attachment to the leaf surface or penetration.

These formulations are prepared in a known manner, for example by mixingthe active compounds with auxiliaries such as, for example, extenders,solvents and/or solid carriers and/or further auxiliaries such as, forexample, surfactants. The formulations are produced either in suitableplants or else before or during application.

Auxiliaries used may be substances capable of giving the formulation ofthe active compound, or the application forms prepared from theseformulations (such as ready-to-use crop protection compositions, forexample, such as spray liquors or seed dressings) particular properties,such as certain physical, technical and/or biological properties.

Suitable extenders are, for example, water, polar and nonpolar organicchemical liquids,for example from the classes of the aromatic andnon-aromatic hydrocarbons (such as paraffins, alkylbenzenes,alkylnaphthalenes, chlorobenzenes), the alcohols and polyols (which, ifappropriate, may also be substituted, etherified and/or esterified), theketones (such as acetone, cyclohexanone), esters including fats and oilsand (polly)ethers, the unsubstituted and substituted amines, amides,lactams (such as N-aIkylpyrrolidones) and lactones, the sulphones andsulphoxides (such as dimethyl sulphoxide).

If the extender used is water, it is also possible to employ, forexample, organic solvents as auxiliary solvents. Essentially, suitableliquid solvents are: aromatics such as xylene, toluene oralkylnaphthalenes, chlorinated aromatics and chlorinated aliphatichydrocarbons such as chlorobenzenes, chloroethylenes or methylenechloride, aliphatic hydrocarbons such as cyclohexane or paraffins, forexample mineral oil fractions, mineral and vegetable oils, alcohols suchas butanol or glycol and their ethers and esters, ketones such asacetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone,strongly polar solvents such as dimethylformamide and dimethylsulphoxide, and also water.

In principle it is possible to use all suitable solvents. Examples ofsuitable solvents are aromatic hydrocarbons, such as xylene, toluene oralkyinaphthalenes, chlorinated aromatic or chlorinated aliphatichydrocarbons, such as chlorobenzene, chloroethylene or methylenechloride, aliphatic hydrocarbons, such as cyclohexane, paraffins,petroleum fractions, mineral and vegetable oils, alcohols, such asmethanol, ethanol, isopropanol, butanol or glycol and their ethers andesters, ketones such as acetone, methyl ethyl ketone, methyl isobutylketone or cyclohexanone, strongly polar solvents, such as dimethylsulphoxide, and also water.

In principle it is possible to use all suitable carriers. Usefulcarriers include especially: for example ammonium salts and groundnatural minerals such as kaolins, clays, talc, chalk, quartz,attapulgite, montmorillonite or diatomaceous earth, and ground syntheticminerals such as finely divided silica, alumina and natural andsynthetic silicates, resins, waxes and/or solid fertilizers, Mixtures ofsuch carriers may also be used. Useful solid carriers for granulesinclude: for example crushed and fractionated natural rocks such ascalcite, marble, pumice, sepiolite, dolomite, and synthetic granules ofinorganic and organic meals, and also granules of organic material suchas sawdust, paper, coconut shells, maize cobs and tobacco stalks.

Liquefied gaseous extenders or solvents can also be used. Particularlysuitable extenders or carriers are those which are gaseous at ambienttemperature and under atmospheric pressure, for example aerosolpropellant gases, such as halohydrocarbons, and also butane, propane,nitrogen and carbon dioxide.

Examples of emulsifiers and/or foam formers, dispersants or wettingagents with ionic or nonionic properties, or mixtures of thesesurfactants, are salts of polyacrylic acid, salts of lignosulphonicacid, salts of phenoisulphonic acid or naphthalenesulphonic acid,polycondensates of ethylene oxide with fatty alcohols or with fattyacids or with fatty amines, with substituted phenols (preferablyalkylphenols or arylphenols), salts of sulphosuccinic esters, taurinederivatives (preferably alkyl taurates), phosphoric esters ofpolyethoxylated alcohols or phenols, fatty esters of polyols, andderivatives of the compounds containing sulphates, sulphonates andphosphates, for example alkylaryl polyglycol ethers, alkylsulphonates,alkyl sulphates, arylsulphonates, protein hydrolysates, lignosulphitewaste liquors and methylcellulose. The presence of a surfactant isadvantageous if one of the active compounds and/or one of the inertcarriers is insoluble in water and when the application takes place inwater.

It is possible to use dyes such as inorganic pigments, for example ironoxide, titanium oxide and Prussian Blue, and organic dyes such asalizarin dyes, azo dyes and metal phthalocyanine dyes, and tracenutrients such as salts of iron, manganese, boron, copper, cobalt,molybdenum and zinc as further auxiliaries in the formulations and theuse forms derived therefrom.

Stabilizers, such as low-temperature stabilizers, preservatives,antioxidants, light stabilizers or other agents which improve chemicaland/or physical stability, may also be present. Foam formers orantifoams may also be present.

Tackifiers such as carboxymethylcellulose and natural and syntheticpolymers in the form of powders, granules or latices, such as gumarabic, polyvinyl alcohol and polyvinyl acetate, or else naturalphospholipids such as cephalins and lecithins and syntheticphospholipids may also be present as additional auxiliaries in theformulations and the use forms derived therefrom. Other possibleauxiliaries are mineral and vegetable oils.

If appropriate, the formulations and the use forms derived therefrom mayalso comprise further auxiliaries. Examples of such additives includefragrances, protective colloids, binders, adhesives, thickeners,thixotropic agents, penetrants, retention promoters, stabilizers,sequestrants, complexing agents, humectants, spreaders. In general, theactive compounds can be combined with any solid or liquid additivecustomarily used for formulation purposes.

Useful retention promoters include all those substances which reduce thedynamic surface tension, for example dioctyl sulphosuccinate, orincrease the viscoelasticity, for example hydroxypropylguar polymers.

Suitable penetrants in the present context are all those substancesWhich are usually used for improving the penetration of agrochemicalactive compounds into plants. Penetrants are defined in this context bytheir ability to penetrate from the (generally aqueous) spray liquorand/or from the spray coating into the cuticle of the plant and therebyincrease the mobility of active compounds in the cuticle. The methoddescribed in the literature (Baur et al., 1997, Pesticide Science 51,131-152) can be used for determining this property. Examples includealcohol alkoxylates such as coconut fatty ethoxylate (10) or isotridecylethoxylate (12), fatty acid esters, for example rapeseed oil methylester or soya oil methyl ester, fatty amine alkoxylates, for exampletallowamine ethoxylate (15), or ammonium and/or phosphonium salts, forexample ammonium sulphate or diammonium hydrogenphosphate.

The active compound content of the use forms prepared from thecommercially available formulations may vary within wide limits. Theactive compound concentration of the use forms is in the range of from0.00000001 to 97% by weight of active compound, preferably in the rangeof from 0.0000001 to 97% by weight, particularly preferably in the rangeof from 0.000001 to 83% by weight or 0.000001 to 97% by weight, and veryparticularly preferably in the range of from 0.0001 to 1% by weight.

The active compound combinations according to the invention can bepresent in their commercially available formulations and in the useforms, prepared from these formulations, as a mixture with other activecompounds, such as insecticides, attractants, sterilizing agents,bactericides, acaricides, nematicides, fungicides, growth-regulatingsubstances, herbicides, safeners, fertilizers or semiochemicals.

A mixture with other known active compounds, such as herbicides,fertilizers, growth regulators, safeners, semiochemicals, or else withagents for improving the plant properties, is also possible.

When used as fungicides and/or insecticides, the active compoundcombinations according to the invention can furthermore be present intheir commercially available formulations and in the use forms, preparedfrom these formulations, as a mixture with synergists. Synergists arecompounds which increase the action of the active compounds, without itbeing necessary for the synergist added to be active itself.

When used as fungicides and/or insecticides, the active compoundcombinations according to the invention can furthermore be present intheir commercially available formulations and in the use forms, preparedfrom these formulations, as a mixture with inhibitors which reducedegradation of the active compound after use in the environment of theplant, on the surface of parts of plants or in plant tissues.

The compounds are employed in a customary manner appropriate for the useforms.

All plants and plant parts can be treated in accordance with theinvention. Plants are understood here to mean all plants and plantpopulations, such as desired and undesired wild plants or crop plants(including naturally occurring crop plants). Crop plants can be plantswhich can be obtained by conventional breeding and optimization methodsor by biotechnological and genetic engineering methods or combinationsof these methods, including the plant varieties which can or cannot beprotected by varietal property rights. Parts of plants are to beunderstood as meaning all above-ground and below-ground parts and organsof plants, such as shoot, leaf, flower and root, examples which may bementioned being leaves, needles, stems, trunks, flowers, fruit-bodies,fruits and seeds and also roots, tubers and rhizomes. The plant partsalso include harvested material and also vegetative and generativepropagation material, for example fruits, seeds, cuttings, tubers,rhizomes, slips, seed, bulbils, layers and runners.

Treatment according to the invention of the plants and plant parts withthe active compound combinations is carried out directly or by allowingthe compounds to act on the surroundings, environment or storage spaceby the customary treatment methods, for example by immersion, spraying,evaporation, fogging, scattering, painting on, injection and, in thecase of propagation material, in particular in the case of seeds, alsoby applying one or more coats. Here, the active compound combinationscan be prepared prior to the treatment by mixing the individual activecompounds. Alternatively, the treatment is carried out successively byinitially using a compound of the formula (I) or (I-1.), followed bytreatment with an active compound of group II. However, it is alsopossible to treat the plants or plant parts first with an activecompound of group II, followed by treatment with a compound of theformula I or (I-1).

The following plants may be mentioned as plants which can be treatedaccording to the in invention: cotton, flax, grapevine, fruit,vegetables, such as Rosaceae sp. (for example pome fruits such as applesand pears, but also stone fruits such as apricots, cherries, almonds andpeaches, and oft fruits such as strawberries), Ribesioidae sp.,Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp.,Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceaesp. (for example banana plants and banana plantations), Rubiaceae sp.(for example coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. (forexample lemons, oranges and grapefruit); Solanaceae sp. (for exampletomatoes), Liliaceae sp., Asteraceae sp. (for example lettuce),Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp.(for example cucumber), Alliaceae sp. (for example leeks, onions),Papilionaceae sp. (for example peas); major crop plants such asGramineae sp. (for example maize, turf, cereals such as Wheat, rye,rice, barley, oats, millet and triticale), Asteraceae sp. (for examplesunflower), Brassicaceae sp. (for example white cabbage, red cabbage,broccoli, cauliflower, Brussels sprouts, pale choi, kohlrabi, radishesand oilseed rape, mustard, horseradish and cress), Fabacae sp. (forexample beans, peanuts), Papilionaceae sp. (for example soya bean),Solanaceae sp. (for example potatoes), Chenopodiaceae sp. (for examplesugar beet, fodder beet, Swiss chard, beetroot); useful plants andornamental plants in gardens and forests.

Depending on the plant species or plant varieties, their location andgrowth conditions (soils, climate, vegetation period, diet), thetreatment according to the invention may also result in superadditive(“synergistic”) effects. For example, the following effects exceedingthe effects actually to be expected are possible: reduced applicationrates and/or a widening ofthe activity spectrum and/or an increase inthe activity of the active compounds and compositions which can be usedaccording to the invention, better plant growth, increased tolerance tohigh or low temperatures, increased tolerance to drought or to water orsoil salt content, increased flowering performance, easier harvesting,accelerated maturation, higher harvest yields, bigger fruits, largerplant height, greener leaf colour, earlier flowering, higher qualityand/or a higher nutritional value of the harvested products, highersugar concentration within the fruits, better storage stability and/orprocessibility of the harvested products.

At certain application rates, the active compound combinations accordingto the invention may also have a strengthening effect in plants.Accordingly, they are suitable for mobilizing the defence system of theplant against attack by unwanted phytopathogenic fungi and/ormicroorganisms and/or viruses. This may, if appropriate, be one of thereasons for the enhanced activity of the combinations according to theinvention, for example against fungi. Plant-strengthening(resistance-inducing) substances are to be understood as meaning, in thepresent context, also those substances or combinations of substanceswhich are capable of stimulating the defence system of plants in such away that, when subsequently inoculated with unwanted phytopathogenicfungi and/or microorganisms and/or viruses, the treated plants display asubstantial degree of resistance to these unwanted phytopathogenic fungiand/or microorganisms and/or viruses. In the present case, unwantedphytopathogenic fungi and/or microorganisms and/or viruses areunderstood as meaning phytopathogenic fungi, bacteria and viruses. Thus,the substances according to the invention can be employed for protectingplants against attack by the abovementioned pathogens within a certainperiod of time after the treatment. The period within which protectionis brought about generally extends from 1 to 10 days, preferably 1 to 7days, after the treatment of the plants with the active compounds.

Plants and plant varieties which are preferably treated according to theinvention include all plants which have genetic material which impartsparticularly advantageous, useful traits to these plants (whetherobtained by breeding and/or biotechnological means).

Plants and plant varieties which are also preferably treated accordingto the invention are resistant against one or more biotic stressfactors, i.e. said plants have a better defence against animal andmicrobial pests, such as against nematodes, insects, mites,phytopathogenic fungi, bacteria, viruses and/or viroids.

Plants and plant varieties which may also be treated according to theinvention are those plants characterized by enhanced yieldcharacteristics. Enhanced yield in said plants can be the result of, forexample, improved plant physiology, growth and development, such aswater use efficiency, water retention efficiency, improved nitrogen use,enhanced carbon assimilation, improved photosynthesis, increasedgermination efficiency and accelerated maturation. Yield can furthermore be affected by improved plant architecture (under stress andnon-stress conditions), including early flowering, flowering control forhybrid seed production, seedling vigour, plant size, internode numberand distance, root growth, seed size, fruit size, pod size, pod or earnuber, seed number per pod or ear, seed mass, enhanced seed filling,reduced seed dispersal, reduced pod dehiscence and lodging resistance.Further yield traits include seed composition, such as carbohydratecontent, protein content, oil content and composition, nutritionalvalue, reduction in anti-nutritional compounds, improved processabilityand better storage stability.

Plants that may be treated according to the invention are hybrid plantsthat already express the characteristics of heterosis, or hybrid vigour,which results in generally higher yield, increased vigour, better healthand better resistance towards biotic and abiotic stress factors. Suchplants are typically made by crossing an inbred male-sterile parent line(the female parent) with another inbred male-fertile parent line (themale parent). Hybrid seed is typically harvested from the male-sterileplants and sold to growers. Male-sterile plants can sometimes (e.g. inmaize) be produced by detasseling (i.e. the mechanical removal of themale reproductive organs or male flowers) but, more typically, malesterility is the result of genetic determinants in the plant genome. Inthat case, and especially when seed is the desired product to beharvested from the hybrid plants, it is typically useful to ensure thatmale fertility in hybrid plants, which contain the genetic determinantsresponsible for male sterility, is fully restored. This can beaccomplished by ensuring that the male parents have appropriatefertility restorer genes which are capable of restoring the malefertility in hybrid plants that contain the genetic determinantsresponsible for male sterility. Genetic determinants for male sterilitymay be located in the cytoplasm. Examples of cytoplasmic male sterility(CMS) were for instance described in Brassica species (WO 1992/005251,WO 1995/009910, WO 1998/27806, WO 2005/002324, WO 2006/021972 and U.S.Pat. No. 6,229,072). However, genetic determinants for male sterilitycan also be located in the nuclear genome. Male-sterile plants can alsobe obtained by plant biotechnology methods such as genetic engineering.A particularly useful means of obtaining male-sterile plants isdescribed in WO 89/10396 in which, for example, a ribonuclease such as abarnase is selectively expressed in the tapetum cells in the stamens.Fertility can then be restored by expression in the tapetum cells of aribonuclease inhibitor such as barstar (e.g. WO 1991/002069).

Plants or plant varieties (obtained by plant biotechnology methods)which may be treated according to the invention are herbicide-tolerantplants, i.e. plants made tolerant to one or more given herbicides. Suchplants can be obtained by selection of plants containing a mutationimparting such herbicide tolerance.

The active compound combinations according to the invention areparticularly suitable for the treatment of seed. Here, particularmention may be made of the combinations according to the inventionmentioned above as preferred or particularly preferred. Thus, most ofthe damage to crop plants which is caused by phytopathogenic fungiand/or animal pests occurs as early as when the seed is infested duringstorage and after the seed is introduced into the soil, and during andimmediately after germination of the plants. This phase is particularlycritical since the roots and shoots of the growing plant areparticularly sensitive and even minor damage can lead to the death ofthe whole plant. Protecting the seed and the germinating plant by theuse of suitable compositions is therefore of particularly greatinterest.

The control of phytopathogenic fungi and/or animal pests by treating theseed of plants has been known for a long time and is the subject ofcontinuous improvements. However, the treatment of seed entails a seriesof problems which cannot always be solved in a satisfactory manner.Thus, it is desirable to develop methods for protecting the seed and thegerminating plant which dispense with the additional application of cropprotection products after sowing or after emergence of the plants. It isfurthermore desirable to optimize the amount of active compound employedin such a way as to provide optimum protection for the seed and thegerminating plant from attack by phytopathogenic fungi and/or animalpests, but without damaging the plant itself by the active compoundemployed. In particular, methods for the treatment of seed should alsotake into consideration the intrinsic fungicidal and/or insecticidalproperties of transgenic plants in order to achieve optimum protectionof the seed and the germinating plant with a minimum of crop protectionproducts being employed.

Accordingly, the present invention also relates in particular to amethod for protecting seed and germinating plants against attack byphytopathogenic fungi and/or animal pests by treating the seed with anactive compound combination according to the invention. The methodaccording to the invention for protecting seed and germinating plantsagainst attack by phytopathogenic fungi and/or animal pests comprises amethod where the seed is treated simultaneously with a compound of theformula (I) and an active compound from group (II) listed above. It alsocomprises a method where the seed is treated at different times with acompound of the formula (I) and an active compound from group (II)listed above.

The invention also relates to the use of the active compoundcombinations according to the invention for treating seed for protectingthe seed and the germinating plant against phytopathogenic fungi and/oranimal pests.

Furthermore, the invention relates to seed treated with an activecompound comb nation according to the invention for protection againstphytopathogenic fungi and/or animal pests. The invention also relates toseed which has been treated simultaneously with a compound of theformula (I) and an active compound from group II. The invention furtherrelates to seed which has been treated at different times with acompound of the formula (I) and an active compound from group II. In thecase of seed which has been treated at different times with a compoundof the formula (I) and an active compound from group II, the individualactive compounds of the inventive active compounds combination may bepresent in different layers on the seed. The layers comprising acompound of the formula (I) and an active compound from group II mayoptionally be separated by an intermediate layer. The invention alsorelates to seed wherein a compound of the formula (I) and an activecompound from group II are applied as part of a coating or as a furtherlayer or further layers in addition to a coating.

An advantage of the present invention is the synergistically increasedinsecticidal activity of the active compound combinations according tothe invention in comparison with the individual insecticidally activecompound, which exceeds the expected activity of the two activecompounds when applied individually. Also advantageous is thesynergictic enhancement of the fungicidal activity of the activecompound combinations according to the invention compared with theindividual fungicidally active compound, which exceeds the expectedactivity of the active compound applied individually. This makespossible an optimization of the amount of active compound employed.

It is likewise to be considered advantageous that the active compoundcombinations according to the invention can be used in particular alsofor transgenic seed.

The active compound combinations according to the invention are suitablefor protecting seed of any plant variety as already mentioned abovewhich is employed in agriculture, in the greenhouse, in forests or inhorticulture. In particular, this takes the form of seed of maize,peanut, canola, oilseed, rape, poppy, soya beans, cotton, beet (forexample sugar beet and fodder beet), rice, millet, wheat, barley, oats,rye, sunflower, tobacco, potatoes or vegetables (for example tomatoes,cabbage species, lettuce, etc.). The active compound combinationsaccording to the invention are likewise suitable for treating the seedof fruit plants and vegetables as already mentioned above. The treatmentof the seed of maize, soya beans, cotton, rice, beet, wheat and canolaor oilseed rape is of particular importance.

Within the context of the present invention, the active compoundcombination according to the invention is applied to the seed eitheralone or in a suitable formulation. Preferably, the seed is treated in astate in which it is stable enough to avoid damage during treatment. Ingeneral, the seed may be treated at any point in time between harvestand sowing. The seed usually used has been separated from the plant andfreed from cobs, shells, stalks, coats, hairs or the flesh of thefruits. Thus, it is possible to use, for example, seed which has beenharvested, cleaned and dried to a moisture content of less than 15% byweight. Alternatively, it is also possible to use seed which, afterdrying, has been treated, for example, with water and then dried again.

When treating the seed, care must generally be taken that the amount ofthe active compound combination according to the invention applied tothe seed and/or the amount of further additives is chosen in such a waythat the germination of the seed is not adversely affected, or that theresulting plant is not damaged. This must be borne in mind in particularin the case of active compounds which can have phytotoxic effects atcertain application rates.

The compositions according to the invention can be applied directly,i.e. without containing any other components and undiluted. In general,it is preferred to apply the compositions to the seed in the form of asuitable formulation. Suitable formulations and methods for treatingseed are known to the person skilled in the art and are described, forexample, in the following documents: U.S. Pat. No. 4,272,417 A, U.S.Pat. No. 4,245,432 A, U.S. Pat. No. 4,808,430 A, U.S. Pat. No. 5,876,739A, US 2003/0176428 A1, WO 2002/080675 A1, WO 2002/028186 A2.

The active compounds which can be used in accordance with the inventioncan be converted into the customary seed-dressing formulations, such assolutions, emulsions, suspensions, powders, foams, slurries or othercoating compositions for seed, and also ULV formulations.

These formulations are prepared in a known manner, by mixing the activecompounds with customary additives such as, for example, customaryextenders and also solvents or diluents, colorants, wetting agents,dispersants, emulsifiers, antifoams, preservatives, secondarythickeners, adhesives, gibberellins and also water.

Colorants which may be present in the seed-dressing formulations whichcan be used in accordance with the invention are all colorants which arecustomary for such purposes. In this context, not only pigments, whichare sparingly soluble in water, but also dyes, which are soluble inwater, may be used. Examples include the dyes known by the namesRhodamine B, C.I. Pigment Red 112 and C.I. Solvent Red 1.

Suitable wetting agents which may be present in the seed-dressingformulations which can be used in accordance with the invention are allsubstances which promote wetting and which are conventionally used forthe formulation of agrochemical active compounds. Preference is given tousing alkylnaphthalenesulphonates, such as diisopropyl ordiisobutylnaphthalenesulphonates.

Suitable dispersants and/or emulsifiers which may be present in theseed-dressing formulations which can be used in accordance with theinvention are all nonionic, anionic and cationic dispersantsconventionally used for the formulation of agrochemical activecompounds. Preference is given to using nonionic or anionic dispersantsor mixtures of nonionic or anionic dispersants. Suitable nonionicdispersants which may be mentioned are, in particular, ethyleneoxide/propylene oxide block polymers, alkylphenol polyglycol ethers andtristryrylphenol polyglycol ether, and their phosphated or sulphatedderivatives. Suitable anionic dispersants are, in particular,lignosulphonates, polyacrylic acid salts and arylsulphonate/formaldehydecondensates.

Antifoams which may be present in the seed-dressing formulations whichcan be used in accordance with the invention are all foam-inhibitingsubstances conventionally used for the formulation of agrochemicalactive compounds. Silicone antifoams and magnesium stearate canpreferably be used.

Preservatives which may be present in the seed-dressing formulationswhich can be used in accordance with the invention are all substanceswhich can be employed for such purposes in agrochemical compositions.Dichlorophene and benzyl alcohol hemiformal may be mentioned by way ofexample.

Secondary thickeners which may be present in the seed-dressingformulations which can be used in accordance with the invention are allsubstances which can be employed for such purposes in agrochemicalcompositions. Cellulose derivatives, acrylic acid derivatives, xanthan,modified clays and finely divided silica are preferred.

Adhesives which may be present in the seed-dressing formulations whichcan be used in accordance with the invention are all customary binderswhich can be employed in seed-dressing products. Polyvinylpyrrolidone,polyvinyl acetate, polyvinyl alcohol and tylose may be mentioned asbeing preferred.

Gibberellins which can be present in the seed-dressing formulationswhich can be used in accordance with the invention are preferably thegibberellins A1, A3 (=gibberellic acid), A4 and A7; gibberellic acid isespecially preferably used. The gibberellins are known (cf. R. Wegler“Chemie der Pflanzenschutz-und Schädlingsbekämpfringsmittel” [Chemistryof the Crop Protection Compositions and Pesticides], Vol. 2, SpringerVerlag, 1970, p. 401-412).

The seed-dressing formulations which can be used in accordance with theinvention can be employed for the treatment of a wide range of seed,including the seed of transgenic plants, either directly or afterpreviously having been diluted with water. In this context, additionalsynergistic effects may also occur in cooperation with the substancesformed by expression.

All mixers which can conventionally be employed for the seed-dressingoperation suitable for treating seed with the seed-dressing formulationswhich can be used in accordance with the invention or with thepreparations prepared therefrom by addition of water. Specifically, aprocedure is followed during the seed-dressing operation in which theseed is placed into a mixer, the specific desired amount ofseed-dressing formulations, either as such or after previously havingbeen diluted with water, is added, and everything is mixed until theformulation is distributed uniformly on the seed. If appropriate, thisis followed by a drying process.

The active compound combinations according to the invention are alsosuitable for increasing the yield of crops. In addition, they havereduced toxicity and are well tolerated by plants.

The active compound combinations according to the invention also exhibita potent strengthening effect in plants. They can therefore be used tomobilize the plant's own defences against attack by undesirablemicroorganisms.

Plant-strengthening (resistance-inducing) substances are to beunderstood as meaning, in the present context, those substances whichare capable of stimulating the defence system of plants in such a waythat the treated plants, when subsequently inoculated with undesirablemicroorganisms, develop a high degree of resistance to thesemicroorganisms.

In the present case, undesired microorganisms are to be understood asmeaning phytopathogenic fungi, bacteria and viruses. Accordingly, thesubstances according to the invention can be used to protect plants fora certain period after the treatment against attack by the pathogensmentioned. The period for which protection is provided generally extendsover 1 to 10 days, preferably 1 to 7 days, after the treatment of theplants with the active compounds.

The plants listed can be treated according to the invention in aparticularly advantageous manner with the active compound mixturesaccording to the invention. The preferred ranges stated above for theactive compound combinations also apply to the treatment of theseplants. Particular emphasis is given to the treatment of plants with theactive compound combinations specifically mentioned in the present text.

The good insecticidal and fungicidal action of the active compoundcombinations according to the invention can be seen from the exampleswhich follow. While the individual active compounds show weaknesses intheir action, the combinations show an action which exceeds a simple sumof actions.

A synergistic effect in insecticides and fungicides is always presentwhen the insecticidal or fungicidal action of the active compoundcombinations exceeds the total of the actions of the active compoundswhen applied individually.

The expected insecticidal or fungicidal action for a given combinationof two active compounds can be calculated according to S. R. Colby(“Calculating Synergistic and Antagonistic Responses of HerbicideCombinations”, Weeds 1967, 15, 20-22), as follows:

If

-   X is the kill rate or efficacy, expressed in % of the untreated    control, when the active compound A is used at an application rate    of m ppm or g/ha,-   Y is the kill rate or efficacy, expressed in % of the untreated    control, when the active compound B is used at an application rate    of n ppm or g/ha,-   E is the kill rate or efficacy, expressed in % of the untreated    control, when the active compounds A and B are used at respective    application rates of m ppm and n ppm or g/ha,-   then

$E = {X + Y - {\frac{X \times Y}{100}.}}$

Here, the kill rate or efficacy is determined in %. 0% means a kill rateor an efficacy that corresponds to that of the control, whereas a killrate of 100% means that all animals are dead and an efficacy of 100%means that no infection is observed.

If the actual fungicidal or insecticidal activity exceeds the calculatedvalue, the activity of the combination is superadditive, i.e. asynergistic effect is present. In this case, the actually observedefficacy must exceed the value calculated using the above formula forthe expected efficacy (E).

EXAMPLE A

Myzus persicae Test

Solvents: 78 parts by weight of acetone 1.5 parts by weight ofdimethylformamide Emulsifier: 0.5 part by weight of alkylaryl polyglycolether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvent andemulsifier, and the concentrate is diluted with emulsifier-containingwater to the desired concentration.

Cabbage leaves (Brassica oleracea) which are heavily infested by thegreen peach aphid (Myzus persicae) are treated by spraying with theactive compound preparation of the desired concentration.

After the desired period of time, the kill in % is determined. 100%means that all of the aphids have been killed; 0% means that none of theaphids have been killed. The kill rates determined are entered intoColby's formula.

In this test, for example, the following active compound combinations inaccordance with the present application show a synergistically enhancedactivity compared to the active compounds applied individually:

TABLE A-1 Myzus persicae test Concen- tration Kill Active compound ing/ha in % after 1^(d) compound (I-1-1)/compound (I-1-7)***  4 0metominostrobin 100 0 found* calc.** compound (I-1-1)/compound (I-1- 4 +100 70 0 7)*** + metominostrobin (1:25) according to the inventionipconazole 100 0 found* calc.** compound (I-1-1)/compound (I-1- 4 + 10070 0 7)*** + ipconazole (1:25) according to the invention mancozeb 100 0found* calc.** compound (I-1-1)/compound (I-1- 4 + 100 70 0 7)*** +mancozeb (1:25) according to the invention mefenoxam 100 0 found*calc.** compound (I-1-1)/compound (I-1- 4 + 100 70 0 7)*** + mefenoxam(1:25) according to the invention azoxystrobin 100 0 found* calc.**compound (I-1-1)/compound (I-1- 4 + 100 70 0 7)*** + azoxystrobin (1:25)according to the invention ***In the mixtures tested of compound(I-1-1)/compound (I-1-7) or compound (I-1-2)/compound (I-1-8), thecompounds (I-1-1) and (I-1-2) were in each case present in an amount ofabout 85% and about 84%, respectively, the compounds (I-1-7) and (I-1-8)were each present in an amount of about 15%.

TABLE A-2 Myzus persicae test Concen- tration Kill Active compound ing/ha in % after 5^(d) compound (I-1-2)/compound (I-1-8)*** 0.16 0tebuconazole 100 0 found* calc.** compound (I-1-2)/compound (I-1- 0.16 +100 70 0 8)*** + tebuconazole (1:625) according to the inventionflutolanil 100 0 found* calc.** compound (I-1-2)/compound (I-1- 0.16 +100 70 0 8)*** + flutolanil (1:625) according to the invention *found =activity found **calc. = activity calculated using Colby's formula ***Inthe mixtures tested of compound (I-1-1)/compound (I-1-7) or compound(I-1-2)/compound (I-1-8), the compounds (I-1-1) and (I-1-2) were in eachcase present in an amount of about 85% and about 84%, respectively, thecompounds (I-1-7) and (I-1-8) were each present in an amount of about15%.

EXAMPLE B

Phaedon cochleariae Larvae Test

Solvents: 78 parts by weight of acetone 1.5 parts by weight ofdimethylformamide Emulsifier: 0.5 part by weight of alkylaryl polyglycolether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvent andemulsifier, and the concentrate is diluted with emuisifier-containingwater to the desired concentration.

Cabbage leaves (Brassica oleracea) are treated by spraying with theactive compound preparation of the desired concentration and populatedwith larvae of the mustard beetle (Phaedon cochleariae) while the leavesare still moist.

After the desired period of time, the kill in % is determined. 100%means that all beetle larvae have been killed; 0% means that none of thebeetle larvae have been killed. The kill rates determined are enteredinto Colby's formula.

In this test, the following active compound combinations in accordancewith the present application show a synergistically enhanced activitycompared to the active compounds applied individually:

TABLE B-1 Phaedon cochleariae larvae test Concen- tration Kill Activecompound in g/ha in % after 2^(d) compound (I-1-1)/compound (I-1-7)***0.8 67 fluopyram 100 0 found* calc.** compound (I-1-1)/compound (I-1-0.8 + 100 83 0 7)*** + fluopyram (1:125) according to the invention

TABLE B-2 Phaedon cochleariae larvae test Concen- tration Kill Activecompound in g/ha in % after 5^(d) compound (I-1-2)/compound (I-1-8)***   0.16 0 compound (I-1-1)/compound (I-1-7)***    0.16 0 prothioconazole100 0 found* calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 100  08)*** + prothioconazole (1:625) according to the invention found*calc.** compound (I-1-1)/compound (I-1- 0.16 + 100 100  0 7)*** +prothioconazole (1:625) according to the invention tebuconazole 100 0found* calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 100  0 8)*** +tebuconazole (1:625) according to the invention found* calc.** compound(I-1-1)/compound (I-1- 0.16 + 100 100  0 7)*** + tebuconazole (1:625)according to the invention triadimenol 100 0 found* calc.** compound(I-1-2)/compound (I-1- 0.16 + 100 33 0 8)*** + triadimenol (1:625)according to the invention found* calc.** compound (I-1-1)/compound(I-1- 0.16 + 100 100  0 7)*** + triadimenol (1:625) according to theinvention fluquinconazole 100 0 found* calc.** compound (I-1-2)/compound(I-1- 0.16 + 100 100  0 8)*** + fluquinconazole (1:625) according to theinvention found* calc.** compound (I-1-1)/compound (I-1- 0.16 + 100 100 0 7)*** + fluquinconazole (1:625) according to the inventionfluoxastrobin 100 0 found* calc.** compound (I-1-2)/compound (I-1-0.16 + 100 33 0 8)*** + fluoxastrobin (1:625) according to the inventionfound* calc.** compound (I-1-1)/compound (I-1- 0.16 + 100 67 0 7)*** +fluoxastrobin (1:625) according to the invention trifloxystrobin 100 0found* calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 67 0 8)*** +trifloxystrobin (1:625) according to the invention found* calc.**compound (I-1-1)/compound (I-1- 0.16 + 100 83 0 7)*** + trifloxystrobin(1:625) according to the invention triazoxide 100 0 found* calc.**compound (I-1-2)/compound (I-1- 0.16 + 100 67 0 8)*** + triazoxide(1:625) according to the invention penflufen 100 0 found* calc.**compound (I-1-1)/compound (I-1- 0.16 + 100 83 0 7)*** + penflufen(1:625) according to the invention fluopicolide 100 0 found* calc.**compound (I-1-2)/compound (I-1- 0.16 + 100 33 0 8)*** + fluopicolide(1:625) according to the invention found* calc.** compound(I-1-1)/compound (I-1- 0.16 + 100 33 0 7)*** + fluopicolide (1:625)according to the invention fenamidone 100 0 found* calc.** compound(I-1-2)/compound (I-1- 0.16 + 100 100  0 8)*** + fenamidone (1:625)according to the invention found* calc.** compound (I-1-1)/compound(I-1- 0.16 + 100 100  0 7)*** + fenamidone (1:625) according to theinvention carpropamid 100 0 found* calc.** compound (I-1-2)/compound(I-1- 0.16 + 100 67 0 8)*** + carpropamid (1:625) according to theinvention found* calc.** compound (I-1-1)/compound (I-1- 0.16 + 100 83 07)*** + carpropamid (1:625) according to the invention isotianil 100 0found* calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 100  0 8)*** +isotianil (1:625) according to the invention found* calc.** compound(I-1-1)/compound (I-1- 0.16 + 100 100  0 7)*** + isotianil (1:625)according to the invention pencycuron 100 0 found* calc.** compound(I-1-1)/compound (I-1- 0.16 + 100 100  0 7)*** + pencycuron (1:625)according to the invention fludioxonil 100 0 found* calc.** compound(I-1-2)/compound (I-1- 0.16 + 100 67 0 8)*** + fludioxonil (1:625)according to the invention ipconazole 100 0 found* calc.** compound(I-1-2)/compound (I-1- 0.16 + 100 33 0 8)*** + ipconazole (1:625)according to the invention found* calc.** compound (I-1-1)/compound(I-1- 0.16 + 100 100  0 7)*** + ipconazole (1:625) according to theinvention imazalil 100 0 found* calc.** compound (I-1-2)/compound (I-1-0.16 + 100 100  0 8)*** + imazalil (1:625) according to the inventionmancozeb 100 0 found* calc.** compound (I-1-1)/compound (I-1- 0.16 + 10083 0 7)*** + mancozeb (1:625) according to the invention metalaxyl 100 0found* calc.** compound (I-1-1)/compound (I-1- 0.16 + 100 83 0 7)*** +metalaxyl (1:625) according to the invention mefenoxam 100 0 found*calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 83 0 8)*** +mefenoxam (1:625) according to the invention found* calc.** compound(I-1-1)/compound (I-1- 0.16 + 100 83 0 7)*** + mefenoxam (1:625)according to the invention sedaxane 100 0 found* calc.** compound(I-1-1)/compound (I-1- 0.16 + 100 100  0 7)*** + sedaxane (1:625)according to the invention azoxystrobin 100 0 found* calc.** compound(I-1-2)/compound (I-1- 0.16 + 100 50 0 8)*** + azoxystrobin (1:625)according to the invention found* calc.** compound (I-1-1)/compound(I-1- 0.16 + 100 83 0 7)*** + azoxystrobin (1:625) according to theinvention boscalid 100 0 found* calc.** compound (I-1-1)/compound (I-1-0.16 + 100 67 0 7)*** + boscalid (1:625) according to the inventionflutolanil 100 0 found* calc.** compound (I-1-1)/compound (I-1- 0.16 +100 83 0 7)*** + flutolanil (1:625) according to the invention *found =activity found **calc. = activity calculated using Colby's formula ***Inthe mixtures tested of compound (I-1-1)/compound (I-1-7) or compound(I-1-2)/compound (I-1-8), the compounds (I-1-1) and (I-1-2) were in eachcase present in an amount of about 85% and about 84%, respectively, thecompounds (I-1-7) and (I-1-8) were each present in an amount of about15%.

EXAMPLE C

Spodoptera frugiperda Larvae Test

Solvents: 78 parts by weight of acetone 1.5 parts by weight ofdimethylformamide Emulsifier: 0.5 part by weight of alkylaryl polyglycolether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvent andemulsifier, and the concentrate is diluted with emulsifier-containingwater to the desired concentration;

Cabbage leaves (Brassica oleracea) are treated by being sprayed withwits the preparation of active compound of the desired concentration andare populated with larvae of the armyworm (Spodoptera frugiperda) whilethe leaves are still moist.

After the desired period of time, the kill in % is deterirdned. 100%means that all caterpillars have been killed; 0% means that none of thecaterpillars have been killed. The kill rates determined are enteredinto Colby's formula.

In this test, the following active compound combinations in accordancewith the present application show a synergistically enhanced activitycompared to the active compounds applied individually:

TABLE C-1 Spodoptera frugiperda larvae test Concen- tration Kill Activecompound in g/ha in % after 2^(d) compound (I-1-2)/compound (I-1-8)***0.16 67  compound (I-1-1)/compound (I-1-7)*** 4 0 0.8 0 0.16 0 penflufen100 0 found* calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 100 678)*** + penflufen (1:625) according to the invention imazalil 100 0found* calc.** compound (I-1-2)/compound (I-1- 0.16 + 100 100 67 8)*** +imazalil (1:625) according to the invention *found = activity found**calc. = activity calculated using Colby's formula ***In the mixturestested of compound (I-1-1)/compound (I-1-7) or compound (I-1-2)/compound(I-1-8), the compounds (I-1-1) and (I-1-2) were in each case present inan amount of about 85% and about 84%, respectively, the compounds(I-1-7) and (I-1-8) were each present in an amount of about 15%.

TABLE C-2 Spodoptera frugiperda larvae test Concen- tration Kill Activecompound in g/ha in % after 6^(d) compound (I-1-1)/compound (I-1-7)***0.16 33 fosetyl-aluminium 500 0 found* calc.** compound (I-1-1)/compound(I-1- 0.16 + 500 67 33 7)*** + fosetyl-aluminium (1:3125) according tothe invention *found = activity found **calc. = activity calculatedusing Colby's formula ***In the mixtures tested of compound(I-1-1)/compound (I-1-7) or compound (I-1-2)/compound (I-1-8), thecompounds (I-1-1) and (I-1-2) were in each case present in an amount ofabout 85% and about 84%, respectively, the compounds (I-1-7) and (I-1-8)were each present in an amount of about 15%.

EXAMPLE D

Aphis gossypii Test

Solvent: 7 parts by weight of dimethylformamide Emulsifier: 2 parts byweight of alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvent andemulsifier, and the concentrate is diluted with emulsifier-containingwater to the desired concentration.

Cotton plants (Gossypium hirsutum) severely infested by the cotton aphid(Aphis gossypii) are treated by spraying with the active compoundpreparation in the desired concentration.

After the desired period of time, the kill in % is determined. 100%means that all of the aphids have been killed; 0% means that none of theaphids have been killed. The kill rates determined a.re entered intoColby's formula.

In this test, the following active compound combination in accordancewith the present application shows a synergistically enhanced activitycompared to the compounds applied individually:

TABLE D Aphis gossypii test Concen- tration Active compound ppm Kill in% after 1 d compound (I-1-1)/compound (I-1-7)***  4 102,6-DIMETHYL-1H,5H- 500  0 [1,4]DITHIINO[2,3-C:5,6-C′]DIPYRROLE-1,3,5,7(2H,6H)- TETRONE found* calc.** compound(I-1-1)/compound (I-1- 4 + 500 45 10 7)*** + 2,6-DIMETHYL-1H,5H-[1,4]DITHIINO[2,3-C:5,6- C′]DIPYRROLE-1,3,5,7(2H,6H)- TETRONE (1:125)according to the invention Kill in % after 2 d compound (I-1-1)/compound(I-1-7)***  20 35 fluopyram 500  0 found* calc.** compound(I-1-1)/compound (I-1- 20 + 500  60 35 7)*** + fluopyram (1:25)according to the invention Kill in % after 3 d compound (I-1-2)/compound(I-1-8)***  4 10 2,6-DIMETHYL-1H,5H- 500  0 [1,4]DITHIINO[2,3-C:5,6-C′]DIPYRROLE-1,3,5,7(2H,6H)- TETRONE found* calc.** compound(I-1-2)/compound (I-1- 4 + 500 65 10 8)*** + 2,6-DIMETHYL-1H,5H-[1,4]DITHIINO[2,3-C:5,6- C′]DIPYRROLE-1,3,5,7(2H,6H)- TETRONE (1:125)according to the invention *found = activity found **calc. = activitycalculated using the Colby formula ***In the mixtures tested of compound(I-1-1)/compound (I-1-7) or compound (I-1-2)/compound (I-1-8), thecompounds (I-1-1) and (I-1-2) were in each case present in an amount ofabout 85% and about 84%, respectively, the compounds (I-1-7) and (I-1-8)were each present in an amount of about 15%.

EXAMPLE E

Myzus persicae Test (Run-Off Application)

Solvent: 7 parts by weight of dimethylformamide Emulsifier: 2 parts byweight of alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvent andemulsifier, and the concentrate is diluted with emulsifier-containingwater to the desired concentration.

Cabbage leaves (Brassica oleracea) which are heavily infested by thegreen peach aphid (Myzus persicae) are treated by spraying to run-offpoint with the active compound preparation of the desired concentration.

After the desired period of time, the kill in % is determined. 100%means that all of the aphids have been killed; 0% means that none of theaphids have been killed. The kill rates determined are entered intoColby's formula.

In this test, the following active compound combination in accordancewith the present application shows a synergistically enhanced activitycompared to the compounds applied individually:

TABLE E Myzus persicae test Concen- tration Kill Active compound ppm in% after 1 d compound (I-1-1)/compound (I-1- 4 50 7)***2,6-DIMETHYL-1H,5H- 500 0 [1,4]DITHIINO[2,3-C:5,6-C′]DIPYRROLE-1,3,5,7(2H,6H)- TETRONE found* calc.** compound(I-1-1)/compound (I-1- 4 + 500 70 50 7)*** + 2,6-DlMETHYL-1H,5H-[1,4]DITHIINO[2,3-C:5,6- C′]DIPYRROLE-1,3,5,7(2H,6H)- TETRONE (1:125)according to the invention *found = activity found **calc. = activitycalculated using the Colby formula ***In the mixtures tested of compound(I-1-1)/compound (I-1-7) or compound (I-1-2)/compound (I-1-8), thecompounds (I-1-1) and (I-1-2) were in each case present in an amount ofabout 85% and about 84%, respectively, the compounds (I-1-7) and (I-1-8)were each present in an amount of about 15%.

1. An active compound combination comprising a synergistically effectivecombination of at least one compound of forntula (I)

in which R¹ represents hydrogen, amino, hydroxyl or representsC₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl or C₃-C₆-cycloalkyl, each ofwhich is optionally mono- or polysubstituted by identical or differentsubstituents, where the substituents independently of one another may beselected from the group consisting of halogen, cyano, nitro, hydroxyl,C₁-C₄-alkoxy, C₁-C₄-alkylthyio, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphonyl, (C₁-C₄-alkoxy)carbonyl, C₁-C₄-alkylamino,di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino and(C₁-C₄-alkyl)-C₃-C₆-cycloalkylamino, R² represents hydrogen,C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,C₁-C₄-alkoxy, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,C₃-C₆-cycloalkylamino, C₁-C₆-alkoxycarbonyl or C₁-C₆-alkylcarbonyl, R³represents hydrogen or represents C₁-C₆-alkyl, C₁-C₆-alkoxy,C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₁₂-cycloalkyl,C₃-C₁₂-cycloalkyl-C₁-C₆-alkyl, each of which is optionally mono- orpolysubstituted by identical or different substituents, where thesubstituents independently of one another may be selected from the groupconsisting of amino, C₃-C₆-cycloalkylamino, halogen, cyano, carboxyl,carbamoyl, nitro, hydroxyl, C₁-C₆-alkyl, C₁-C₆-haloalkyl,C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₆-alkoxycarbonyl,C₁-C₆-alkylcarbonyl, C₃-C₆-trialkylsilyl and a saturated or partiallysaturated heterocyclic ring, an aromatic or heteroaromatic ring or asaturated, partially saturated or aromatic heterobicyclic ring, wherethe ring or the ring system is optionally mono- or polysubstituted byidentical or different substituents from the group consisting of SF,halogen, cyano, nitro, hydroxyl, amino, carboxyl, carbamoyl,aminosulphanyl, C₁-C₆-alkyl, C₃-C₆cycloalkyl, C₁-C₄-alkoxy,C₁-C₆-haloalkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-akylsulphimino,C₁-C₄-akylsulphimino-C₁-C₄-alkyl,C₁-C₄-alkylsulphinyl-C₂-C₅-alkylcarbonyl, C₁-C₄-alkylsulphoximino,C₁-C₄-alkylsulphoximino-C₁C-C₄-alkyl,C₁-C₄-alkylsulphoximino-C₂-C₅-alkylcarbonyl, C₁-C₅-alkoxycarbonyl,C₁-C₆-alkylcarbonyl, C₃-C₆-trialkylsilyl, benzyl C₂-C₆-alkenyl,C₂-C₆-alkynyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,C₃-C₆-halocycloalkyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄ alkyl)amino,C₃-C₆-cycloalkylamino and a 3- to 6-membered ring, where the ring mayoptionally be substituted by C₁-C₆-alkyl, halogen, cyano, nitro,halo-(C₁-C₆)-alkyl, C₁-C₆-alkoxy or halo-(C₁-C₆)-alkoxy, or R³represents C₁-C₆-alkoxycarbonyl, C₁-C₆-alkylcarbonyl,C₁-C₆-alkylaminocarbonyl or di-(C₁-C₆)-alkylaminocarbonyl, or R³furthermore represents a 5- or 6-membered aromatic or heteroaromaticring, a 4-, 5- or 6-membered partially saturated ring or saturatedheterocyclic ring, or a saturated, partially saturated or aromaticheterobicyclic ring which may optionally contain one to threeheteroatoms from the group consisting of O, S and N, which rings aremono- or polysubstituted by identical or different substituents, wherethe substituents independently of one another are selected from thegroup consisting of SF5, halogen, cyano, nitro, hydroxyl, amino,carboxyl, carbamoyl, C₁-C₆-alkyl, C₃-C₆-cycloalkyl, C₁-C₄-alkoxy,C₁-C₆-haloalkyl, C₁-C₄-haloalkoxy, C₁-C₄alkylthio, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphonyl, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphinyl-C₁-C₄-alkyl,C₁-C₄-alkylsulphinyl-C₁-C₅-alkylcarbonyl, C₁-C₄-alkylsulphoximino,C₁-C₄-alkylsulphoximino-C₁-C₄-alkyl,C₁-C₄-alkylsulphoximino-C₂-C₅-alkylcarbonyl, C₁-C₆-alkoxycarbonyl,C₁-C₆-alkylcarbonyl, C₃-C₆-trialkylsilyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl,C₁-C₄-haloalkylthio, C₁-₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl,C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino and C₃-C₆-cycloalkylamino, or a3- to 6-membered ring, where the ring may optionally be substituted byC₁-C₆-alkyl, halogen, cyano, nitro, halo-(C₁-C₆)-alkyl C₁-C₆-alkoxy orhalo-(C₁-C₆)-alkoxy, R² and R³ may be linked with each other via two tosix carbon atoms and form a ring which optionally additionally containsa further nitrogen, sulphur or oxygen atom and which may optionally bemono- to tetrasubstituted by C₁-C₂-alkyl, C₁-C₂-haloalkyl, halogen,cyano, amino C₁-C₂-alkoxy or C₁-C₂-haloalkoxy, R², R³ furthermoretogether represent —S(C₁-C₄-alkyl)₂ or ═S(O)(C₁-C₄-alkyl)₂, R⁴represents hydrogen, halogen, cyano, nitro C₁-C₄-alkyl, C₁-C₄-haloalkyl,C₂-C₆-alkenyl, C₂-C₆-haloalkenyl, C₂-C₆-alkynyl, C₁-C₄-alkoxy,C₁-C₄-haloalkoxy, SF₅, C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,C₃-C₆-cycloalkylamino, (C₁-C₄-alkoxy)imino,(C₁-C₄-alkyl)(C₁-C₄-alkoxy)imino, (C₁-C₄-haloalkyl)(C₁-C₄-alkoxy)iminoor C₃-C₆-trialkylsilyl, or two R⁴, via adjacent carbon atoms, form aring which represents —(CH₂)₃—, —(CH₂)₄—, —(CH₂)₅—, —(CH═CH—)₂—,—OCH₂O—, —O(CH₂)₂O—, —OCF₂O—, —(CF₂)₂O—, —O(CF₂)₂O—, —(CH═CH—CH═N)— or—(CH═CH—N═CH)—, two R⁴ furthermore, via adjacent carbon atoms, form thefused rings below, which are optionally mono- or polysubstituted byidentical or different substituents, where the substituentsindependently of one another may be selected from the group consistingof hydrogen, C₁-C₆-alkyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl,C₃-C₆-halocycloalkyl, halogen, C₁-C₆-alkoxy, C₁-C₄-alkylthio-(C₁-C₆-alkyl), C₁-C₄-alkylsulphinyl-(C₁-C₆-alkyl),C₁-C₄-alkylsulphonyl-(C₁-C₆-alkyl), C₁-C₄-alkylamino,di-(C₁-C₄-alkyl)amino and C₃-C₆-cycloalkylamino,

n represents 0 to 3, R³ represents C₁-C₆-alkyl, C₃-C₆-cycloalkyl,C₁-C₆-haloalkyl, C₁-C₆-halocycloalkyl, C₂-C₆-alkenyl, C₂-C₆-haloalkenyl,C₂-C₆-alkynyl, C₂-C₆-haloalkynyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl,C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl,halogen, cyano, nitro or C₃-C₆-trialkylsilyl, Q_(X) represents anaromatic or heteroaromatic 5- or 6-membered ring which is optionallymono- or polysubstituted by identical or different R⁷ substituents andwhich may contain 1-3 heteroatoms from the group consisting of N, S andO, A represents optionally mono- or polysubstituted—(C₂-C₆-alkenylene)-, —(C₂-C₆-alkynylene)-, —R⁸—(C₃-C₆-cycloalkyl)-R⁸—,—E⁸—O—R⁸—, —R⁸—S—R⁸—, —R⁸—S(═O)—R⁸—, —R⁸—S(═O)₂—R⁸—,—R⁸—N(C₁-C₆-alkyl)-R⁸—, —R⁸—C═NO(C₁-C₆-alkyl)-R⁸, —CH[CO₂(C₁-C₆-alkyl)-,—R⁸—C(═O)—R⁸, —R⁸—C(—O)NH—R⁸, R⁸—C(═O)N(C₁-C₆-alkyl)-R⁸,—R⁸—C(═O)NHNH—R⁸—, —R⁸—C(═O)N(C₁-C₆-alkyl)-NH—R⁸—,—R⁸—C(═O)NHN(C₁-C₆-alkyl)-R⁸, —R⁸—O(C═O)—R⁸, —R⁸—O(C═O)NH—R⁸,—R⁸—O(C═O)N(C₁-C₆-alkyl)-R⁸, —R⁸—S(═O)₂NH—R⁸,—R⁸—S(═O)₂N(C₁-C₆-alkyl)-R⁸, —R⁸—S(C═O)—R⁸, —R⁸—S(C═O)NH—R⁸,—R⁸—S(C═O)N(C₁-C₆-alkyl)-R⁸, —R⁸—NHNH—R⁸, —R⁸—NHN(C₁-C₆-alkyl)-R⁸,—R⁸—N(C₁-C₆-alkyl)-NH—R⁸, —R⁸—N(C₁-C₆-alkyl)—N(C₁-C₆-alkyl)-R⁸,—R⁸—N═CH—O—R⁸, —R⁸—NH(C═O)O—R⁸, —R⁸—N(C₁-C₆-alkyl)-(C═O)O—R⁸,—R⁸—NH(C═O)NH—R⁸, —R⁸—NH(C═S)NH—R⁸, —R⁸—NHS(═O)₂—R⁸, R⁸—NH—R⁸,R⁸—C(═O)—C(═O)—R⁸, R⁸—C(OH)—R⁸, R⁸—NH(C═O)—R⁸, R⁸-Qz-R⁸,R⁸—C(═N—NR′₂)-R⁸, R⁸—C(═C—R′₂)-R⁸ or —R⁸—N(C₁-C₆-alkyl)S(═O)₂—R⁸, wherethe substituents independently of one another may be selected from thegroup consisting of halogen, cyano, nitro, hydroxyl, C₁-C₆-alkyl,C₁-C₆-alkyloxy, halo-C₁-C₆-alkyl, amino, (C₁-C₆-alkyl)amino,di-(C₁-C₆-alkyl)amino and C₃-C₆-cycloalkyl where —(C₃-C₆-cycloalkyl)- inthe ring may optionally contain 1 or 2 heteroatoms selected from thegroup consisting of N, S and O, R⁸ represents straight-chain or branched—(C₁-C₆-alkylene)- or represents a direct bond, where a plurality of R⁸independently of one another represent straight-chain or branched—(C₁-C₆-alkylene)- or represent a direct bond, for example, R⁸—O—R⁸—represents —(C₁-C₆-alkylene)-O—(C₁-C₆-alkylene)-, —(C₁-C₆-alkylene)-O—,—O—(C₁-C₆-alkylene)-, or —O—, where R′ represents alkyl, alkylcarbonyl,alkenyl, alkynyl, which may optionally be mono- or polysubstituted byhalogen, Q_(Z) represents a 3- or 4-membered partially saturated orsaturated or a 5- or 6-membered partially saturated, saturated oraromatic ring or represents a 6- to 10-membered bicyclic ring system,where the ring or the bicyclic ring system may optionally contain 1-3heteroatoms from the group consisting of N, S and O, where the ring orthe bicyclic ring system is optionally mono- or polysubstituted byidentical or different substituents and where the substituentsindependently of one another may be selected from the group consistingof hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,C₃-C₆-cycloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,C₃-C₆-halocycloalkyl, halogen, cyano, carbamoyl, nitro, hydroxyl,C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄ alkylthio, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,C₃-C₆-cycloalkylamino, (C₁-C₆-alkyl)carbonyl, (C₁-C₆-alkoxy)carbonyl,(C₁-C₆-alkyl)aminocarbonyl and di-(C₁-C₄-alkyl)aminocarbonyl, Q_(Y)represents a 5- or 6-membered partially saturated or saturatedheterocyclic or heteroaromatic ring or an aromatic 8-, 9- or 10-memberedfused heterobicyclic ring system, where the ring or the ring system isoptionally mono- or polysubstituted by identical or differentsubstituents and the substituents independently of one another may beselected from the group consisting of hydrogen, C₁-C₆-alkyl,C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl,C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen,cyano, carboxyl, carbamoyl, nitro, hydroxyl, C₁-C₄-alkoxy,C₁-C₄-haloalkoxy, C₁-C₄-alkylthio, C₁-C₄ alkylsulphinyl,C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino, di-(C₁-C₄-alkyl)amino,C₃-C₆-cycloalkylamino, (C₁-C₆-alkyl)carbonyl, (C₁-C₆-alkoxy)carbonyl,(C₁-C₆-alkyl)aminocarbonyl, di-(C₁-C₄-alkyl)aminocarbonyl,tri-(C₁-C₂)alkylsilyl and (C₁-C₄-alkyl)(C₁-C₄-alkoxy)imino, or where thesubstituents independently of one another may be selected from the groupconsisting of phenyl and a 5- or 6-membered heteroaromatic ring, wherephenyl or the ring may optionally be mono- or polysubstituted byidentical or different substituents from the group consisting ofC₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,C₃-C₆-halocycloalkyl, halogen, cyano, nitro, hydroxyl, C₁-C₄-alkoxy andC₁-C₄-haloalkoxy, R⁷ represents hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl,C₂-C₆-alkynyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl,C₃-C₆-cycloalkoxy or

R⁹ independently of one another represent hydrogen, C₁-C₆-alkyl,C₃-C₆-cycloal C₁-C₆-haloalkyl, halogen, cyano, nitro, C₁-C₄-alkoxy,C₁-C₄-haloalkoxy, C₁-C₄-alkylthio or C₁-C₄-haloalkylthio, p represents 0to 4, Z represents N, CH, CF, CCl, CBr or CI, or an N oxides or saltthereof, and one or more fungicides of group (II) selected from (1)Ergosterol biosynthesis inhibitors, for example aldimorph, azaconazole,bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorphacetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole,fenhexamid, fenpropidin, fenpropimorph, fluquinconazole, flurprimidol,flusilazole, flutriafol, furconazole, furconazole-cis, hexaconazole,imazalil, imazalil sulphate, imibenconazole, ipconazole, metconazole,myclobutanil, naftifin, nuarimol, oxpoconazole, paclobutrazole,pefurazoate, penconazole, piperalin, prochloraz, propiconazole,prothioconazole, pyributicarb, pyrifenox, quinconazole, simeconazole,spiroxamine, tebuconazole, terbinafine, tetraconazole, triadimefon,triadimenol, tridemorph, triflumizole, triforine, triticonazole,uniconazole, uniconazole-p, viniconazole, voriconazole,1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol, methyl1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-H-imidazole-5-carboxylate,N′-{5-difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamide,N-ethyl-N-methyl-M′-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamideandO-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl]1H-imidazole-1-carbothioate,(2) Respiration inhibitors (respiratory chain inhibitors), such as, forexample, bixafen, boscalid, carboxin, diflumetorim, fenfuram, fluopyram,flutolanil, fluxapyroxad, furametpyr, furmecyclox, isopyrazam mixture ofthe syn-epimeric racemate 1RS,4SR,9RS and of the anti-epimeric racemate1RS,4SR,9SR, isopyrazam (anti-epimeric racemate), isopyrazam(anti-epimeric enantiomer 1R,4S,9S), isopyrazam (anti-epimericenantiomer 1S,4R,9R), isopyrazam (syn-epimeric racemate 1RS,4SR,9RS),isopyrazam (syn-epimeric enantiomer 1R,4S,9R), isopyrazam (syn-epimericenantiomer 1S,4R,9S), mepronil, oxycarboxin, penflufen, penthiopyrad,sedaxane, thifluzamid,1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide,N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,5,8-difluoro-N-[2-(2-fluoro-4-[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazoline-4-amine,N-[9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamideandN-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,(3) Respiration inhibitors (respiratory chain inhibitors) acting oncomplex III of the respiratory chain, for example ametoctradin,amisulbrom, azoxystrobin, cyazofamid, coumethoxystrobin, coumoxystrobin,dimoxystrobin, enestroburin, famoxadone, fenamidone, fenoxystrobin,fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin,picoxystrobirt, pyraclostrobin, pyrametostrobin, pyraoxystrobin,pyribencarb, triclopyricarb, trifloxystrobin,(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,(2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide,(2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide,(2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylethenyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide,(2E)-2-{2-[({[(2E,3E)-4-(2,6-dichlorophenyl)but-3-en-2-ylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide,2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide,5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one,methyl(2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulphanyl)methyl]phenyl}-3-methoxyprop-2-enoate,N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide,2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamideand(2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide,(4) Mitosis and cell division inhibitors, for example benomyl,carbendazim, chlorfenazole, diethofencarb, ethaboxam, fluopicolide,fuberidazole, pencycuron, thiabendazole, thiophanate-methyl,thiophanate, zoxamide,5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidineand3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine,(5) Compounds with multisite activity, for example Bordeaux mixture,captafol, captan, chlorothalonil, copper preparations such as copperhydroxide, copper naphthenate, copper oxide, copper oxychloride, coppersulphate, dichlofluanid, dithianon, dodine, dodine free base, ferbam,fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine,iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb,maneb, metiram, metiram zinc, oxine-copper, propamidine, propineb,sulphur and sulphur preparations, for example calcium polysulphide,thiram, tolylfluanid, zineb and ziram, (6) Resistance inductors, forexample acibenzolar-S-methyl, isotianil, probenazole and tiadinil, (7)Amino acid and protein biosynthesis inhibitors, for example andoprim,blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloridehydrate, mepanipyrirn, pyrimethanil and3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,(8) ATP production inhibitors, for example fentin acetate, fentinchloride, fentin hydroxide and silthiofam, (9) Cell wall synthesisinhibitors, for example benthiavaticarb, dimethomorph, flumorph,iprovalicarb, mandipropamid, polyoxins, polyoxorim, validainycin A andvalifenalate, (10) Lipid and membrane synthesis inhibitors, for examplebiphenyl, chloroneb, dicloran, edifenphos, etridiazole, iodocarb,iprobenfos, isoprothiolane, propamocarb, propamocarb hydrochloride,prothiocarb, pyrazophos, quintozene, tecnazene and tolclofos-methyl,(11) Melanin biosynthesis inhibitors, such as for example, carpropamid,diclocymet, fenoxanil, fthalide, pyroquilon, tricyclazole and2,2,2-trifluoroethyl{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate, (12) Nucleicacid synthesis inhibitors, for example benalaxyl, (kiralaxyl),bupirimate, clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazol,metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl and oxolinic acid,(13) Signal transduction inhibitors, for example chlozolinate,fenpiclonil, fludioxonil, iprodione, procymidone, quinoxyfen andvinclozolin, (14) Decouplers, for example binapacryl, dinocap,ferimzorte, fluazinam and meptyldinocap, (15) Further compounds, forexample benthiazole, bethoxazin, capsimycin, carvone, chinomethionat,pyriofenone (chlazafenone), cufraneb, cyflufenamid, cymoxanil,cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine,difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomat,fenpyrazamine, flumetover, fluoromide, flusulfamide, flutianil,fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene,irumamycin, methasulfocarb, methyl isothiocyanate, metrafenon,mildiomycin, natamycin, nickel dimethyldithiocarbamate,nitrothal-isopropyl, octhilinone, oxamocarb, oxyfenthiin,pentachlorophenol and salts thereof, phenothrin, phosphoric acid andsalts thereof, propamocarb-fosetylate, propanos Me-sodium, proquinazid,pyrimorph, pyrrolnitrin, tebutloquin, tecloftalam, tolnifartid,triazoxide, trichlamide, zarilamide,(3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl2-methylpropanoate,1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl 1H-imidazole-1-carboxylate,2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine,2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one,2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,2-0[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone,2-butoxy-6-iodo-3-propyl-4H-chromen-4-one,2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine,2-phenylphenol and salts thereof,3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,3,4,5-trichloropyridine-2,6-dicarbonitrile,3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine,3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine,4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine,5-amino-1,3,4-thiadiazole-2-thiol,5-chloro-N′-phenyl-N′-(prop-2-yn-1-yl)thiophene-2-sulphonohydrazide,5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidine-4-amine,5-fluoro-2-[(4-methylbenyl)oxy]pyrimidine-4-amine,5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidine-7-amine, ethyl(2Z)-3-amino-2-cyano-3-phenylprop-2-enoate,N′-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide,N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(4-chlorophenyl)(cyano)methyl]-3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide,N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,N′-{4-[(3-tert-butyl-4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methylimidoformamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,pentyl{6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylidene]amino}oxy)methyl]pyridin-2-yl}carbamate,phenazine-1-carboxylic acid, quinolin-8-ol, quinolin-8-ol sulphate (2:1)and tert-butyl{6′-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate,(16) further compounds, for example1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide,N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-(4′-ethynylbiphenyl-2-yl)pyridine-3-carboxamide,2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide,5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-[4-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanoneandN-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl-N2-(methylsulphonyl)valinamide,4-oxo-4-[(2-phenylethyl)amino]butanoic acid and but-3-yn-1-yl{6-[({[(Z)-(1-methyl-1H-tetrazol-5-phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate.2. An active compound combination according to claim 1, wherein R¹represents hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,C₃-C₆-cycloalkyl, cyano-(C₁-C₆-alkyl), C₁-C₆-haloalkyl,C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl, C₁-C₄-alkoxy-C₁-C₄-alkyl,C₁-C₄-alkylthio-C₁-C₄-alkyl, C₁-C₄-alkylsulphinyl-C₁-C₄-alkyl orC₁-C₄-alkylsulphonyl-C₁-C₄-alkyl R² represents hydrogen or C₁-C₆-alkyl,R³ represents hydrogen or represents C₁-C₄-alkyl, C₁-C₄-alkoxy,C₂-C₄-alkenyl, C₂-C₄-alkynyl, C₃-C₆-cycloalkyl, each of which isoptionally mono- or polysubstituted by identical or differentsubstituents, where the substituents independently of one another may beselected from the group consisting of halogen, cyano, carboxyl,carbamoyl, nitro, hydroxyl, C₁-C alkyl, C₁-C₄-haloalkyl,C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-alkoxycarbonyl,C₁-C₄-alkylcarbonyl or a phenyl ring or a 4-, 5- or 6-membered aromatic,partially saturated or saturated heterocyclic ring, where the phenylring or heterocyclic ring is optionally mono- or polysubstituted byidentical or different substituents and where the substituentsindependently of one another may be selected from the group consistingof hydrogen, C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl,C₃-C₆-cycloalkyl, C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl, carbamoyl, NO₂,hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio,C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl, C₁-C₄-alkylamino,di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino, (C₁-C₆-alkyl)carbonyl,C₁-C₆-alkoxy)carbonyl or R³ represents C₂-C₄-alkoxycarbonyl,C₂-C₄-alkylcarbonyl, C₂-C₄-alkylaminocarbonyl orC₂-C₄-dialkylaminocarbonyl, or R³ represents a phenyl ring, a 5- or6-membered aromatic heterocyclic ring or a 4-, 5- or 6-memberedpartially saturated or saturated heterocyclic ring which may contain 1-3heteroatoms from the group consisting of N, S and O, where the phenylring or heterocyclic ring is optionally mono- or polysubstituted byidentical or different substituents, and where the substituentsindependently of one another may be selected from the group consistingof hydrogen, C₁-C₄-alkyl, C₂-C₄-alkenyl, C₂-C₄-alkynyl,C₃-C₆-cycloalkyl, C₁-C₄-haloalkyl, C₂-C₄-haloalkenyl, C₂-C₄-haloalkynyl,C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl, carbamoyl, NO₂,hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₁-C₄-alkylsulphinyl, C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio,C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl, C_(l)-C₄-alkylamino,di-(C₁-C₄-alkyl)amino, C₃-C₆-cycloalkylamino, (C₁-C₄-alkyl)carbonyl and(C₁-C₄-alkoxy)carbonyl, R⁴ represents hydrogen, C₁-C₄-alkyl,C₁-C₄-haloalkyl, halogen, cyano, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,C₁-C₄-alkylthio or C₁-C₄-haloalkylthio, two adjacent radicals R⁴likewise represent —(CH₂)₃—, —(CH₂)₄—, —(CH₂)₅—, —(CH═CH—)₂—, —OCH₂O—,—O(CH₂)₂O—, —OCF₂O—, —(CF₂)₂O—, —(CF₂)₂O—, —(CH═CH—CH═N)— or—(CH═CH—N═CH)—, n represents 0, 1 or 2, R⁵ represents C₁-C₄-alkyl,C₃-C₆-cycloalkyl, C₁-C₆-halocycloalkyl, C₂-C₆-alkenyl,C₂-C₄-haloalkenyl, C₂-C₄-alkynyl, C₂-C₄-haloalkynyl, C₁-C₄-alkoxy,C₁-C₄-haloalkoxy, C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl,C₁-C₄-haloalkylsulphonyl, halogen, cyano, nitro or C₃-C₆-trialkylsilyl,Q_(X) represents a 5- or 6-membered heteroaromatic ring which isoptionally mono- or polysubstituted by identical or different R⁷ andwhich may contain 1-3 heteroatoms from the group consisting of N, O andS, or represents phenyl, A represents optionally mono- orpolysubstituted —(C₁-C₄-alkylene)-, —(C₂-C₄-alkenylene)-,—(C₂-C₄-alkynylene)-, —R⁸—(C₃-C₆-cycloalkyl)-R⁸—, —R⁸—O—R⁸—,—R⁸—S(═O)—R⁸—, —R⁸—S(═O)₂—R⁸—, —R⁸—NH—(C₁-C₄-alkyl)-,—R⁸—N(C₁-C₄-alkyl)-R⁸, —R⁸—C═NO(C₁-C₄-alkyl), —R⁸—C(—O)—R⁸,—R⁸—C(—S)—R⁸, —R⁸—C(—O)NH—R⁸, R⁸—C(═O)N(C₁-C₄-alkyl)-R⁸,—R⁸—S(═O)₂NH—R⁸, —R⁸—S(═O)₂N(C₁-C₄-alkyl)-R⁸, —R⁸—NH(C═O)O—R⁸,—R⁸—N(C₁-C₄-alkyl)-(C═O )O—R⁸, —R⁸—NH(C═O)NH—R⁸, —R⁸—NHS(═O)₂—R⁸,—R⁸—N(C₁-C₄-alkyl)S(═O)₂—R⁸, R⁸—NH—R⁸, R⁸—C(═O)—C(═O)—R⁸, R⁸—C(OH)—R⁸ orR⁸-Qz-R⁸, where the substituents independently of one another may beselected from the group consisting of halogen, cyano, nitro, hydroxyl,C₁-C₆-alkyl, C₁-C₆-alkoxy and halo-C₁-C₆-alkyl, Q_(Z) represents a 3- or4-membered partially saturated or saturated or a 5- or 6-memberedpartially saturated, saturated or aromatic ring, where the ring mayoptionally contain 1-3 heteroatoms from the group consisting of N, S andO, where the ring is optionally mono- or polysubstituted by identical ordifferent substituents, and where the substituents independently of oneanother may be selected from the group consisting of hydrogen,C₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,C₃-C₆-halocycloalkyl, halogen, cyano, hydroxyl, C₁-C₄-alkoxy,C₁-C₄-haloalkoxy, C₁-C₄-alkylthio, C₁-C₄-alkylsulphinyl,C₁-C₄-alkylsulphonyl, C₁-C₄-haloalkylthio, C₁-C₄-haloalkylsulphinyl andC₁-C₄-haloalkylsulphonyl, R⁷ represents C₁-C₆-alkyl or represents theradical

R⁷ furthermore represents C₃-C₆-cycloalkoxy, R⁹ independently of oneanother represent hydrogen, halogen, cyano, C₁-C₄-alkyl, C₁-C₄-alkoxy,C₁-C₄-haloalkyl, C₁-C₄-haloalkoxy, C₁-C₄-haloalkylsulphonyl or(C₁-C₄-alkyl)-C₁-C₄-alkoxyimino, p represents 1, 2 or 3, Z represents N,CH, CF, CCl, CBr or CI, R⁸ represents straight-chain or branched—(C₁-C₄-alkylene)- or represents a direct bond, Q_(Y) represents a 5- or6-membered partially saturated or saturated heterocyclic orheteroaromatic ring or an aromatic 8-, 9- or 10-membered fusedheterobicyclic ring system, where the heteroatoms may be selected fromthe group consisting of N, S and O, where the ring or the ring system isoptionally mono- or polysubstituted by identical or differentsubstituents, and where the substituents independently of one anothertray be selected from the group consisting of hydrogen, C₁-C₆-alkyl,C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl, C₁-C₆-haloalkenyl,C₂-C₆-haloalkynyl, C₃-C₆-halocycloalkyl, halogen, cyano, carboxyl,carbamoyl, nitro, hydroxyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy,C₁-C₄-alkylthio, C₁-C₄-alkylsulphonyl, haloalkylthio,C₁-C₄-haloalkylsulphinyl, C₁-C₄-haloalkylsulphonyl, or where thesubstituents independently of one another may be selected from the groupconsisting of phenyl and a 5- or 6-membered heteroaromatic ring, wherephenyl or the ring may optionally be mono- or polysubsthuted byidentical or different substituents from the group consisting ofC₁-C₆-alkyl, C₂-C₆-alkenyl, C₂-C₆-alkynyl, C₃-C₆-cycloalkyl,C₁-C₆-haloalkyl, C₂-C₆-haloalkenyl, C₂-C₆-haloalkynyl,C₃-C₆-halocycloalkyl, halogen, cyano, nitro, hydroxyl, C₁-C₄-alkoxy andC₁-C₄-haloalkoxy.
 3. An active compound combination according to claim1, comprising at least one active compound of formula (I-I)

in which R³ represents hydrogen or represents C₁-C₆-alkyl, C₁-C₆-alkoxy,C₂-C₉-alkenyl, C₂-C₆-alkynyl, C₃-C₁₂-cycloalkyl,C₃-C₁₂-cycloalkyl-C₁-C₆-alkyl, each of which is optionally mono- orpolysubstituted by identical or different substituents, where thesubstituents independently of one another may be selected from the groupconsisting of halogen, amino, cyano, nitro, hydroxyl, C₁-C₆-alkyl,C₃-C₆-cycloalkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₂-C₆-alkoxycarbonyl, C₁-C₆-alkylcarbonyl, C₃-C₆-cycloalkylamino and a5- or 6-membered heteroaromatic ring, R⁴ r epresents halogen, cyano ormethyl, R⁵ represents methyl or chlorine, Z represents N, CCl or CH, Qyrepresents an optionally mono- or polysubstituted 5- or 6-memberedheteroaromatic ring from the group consisting of Q-36 to Q-40, Q43, Q-58to Q-59, Q62, Q63, an aromatic 9-membered fused heterobicyclic ringsystem Q-54 to Q-56 or a 5-membered heterocyclic ring Q-60 to Q-61,where the substituents independently of one another may be selected fromthe group consisting of C₁-C₃-alkyl, C₁-C₃-alkoxy, halogen, cyano,hydroxyl, nitro or C₁-C₂-haloalkoxy, where the compound of formula (I-I)may be present in the form of salts,

and one or more fungicides from group (II).
 4. An active compoundcombination according to claim 3, comprising a mixture of compounds ofFormula (I-1) in which Qy is Q62 and Q63, the ratio of a compound of theformula (I) or (I-1) in which Qy is Q62 to a compound of the Formula(I-1) in which Qy is Q63 being 80:20 to 99:1.
 5. An active compoundcombination according to claim 3, comprising a mixture of compounds ofFormula (I-1) in which Qy is Q58 and Q59, the ratio of a compound of theformula (I-1) in which Qy is Q58 to a compound of the formula (I) or(I-1) in which Qy is Q59 being 80:20 to 99:1.
 6. An active compoundcombinations according to claim 3, wherein R³ represents hydrogen orrepresents C₁-C₆-alkyl, C₁-C₆-alkoxy, C₂-C₆-alkenyl, C₂-C₆-alkynyl,C₃-C₆-cycloalkyl, C₃-C₆-cycloalkyl-C₁-C₆-alkyl, each of which isoptionally mono- or polysubstituted by identical or differentsubstituents, where the substituents independently of one another may beselected from the group consisting of halogen, cyano, amino, hydroxyl,C₁-C₆-alkyl, C₁-C₄-alkoxy, C₁-C₄-haloalkoxy, C₁-C₄-alkylthio,C₃-C₆-cycloalkyl and a 5- or 6-membered heteroaromatic ring whichcontains 1-2 heteroatoms from the group consisting of N, O and S, wheretwo oxygen atoms in the ring are not adjacent, R⁴ represents halogen,cyano or methyl R⁵ represents methyl, Z represents N or CH, Q_(Y)represents a heteroaromatic ring from the group consisting of Q-37,Q-38, Q-39, Q-40, Q43, Q-58, Q-59, Q62 and Q63 which is optionally mono-or polysubstituted by identical or different substituents, or representsa 5-membered heterocyclic ring Q-60, where the substituentsindependently of one another may be selected from the group consistingof methyl, ethyl, cyclopropyl, tert-butyl, chlorine, fluorine, iodine,bromo, cyano, nitro, difluoromethyl, trifluoromethyl, pentafluoroethyl,n-heptafluoropropyl and isoheptafluoropropyl.
 7. An active compoundcombination according to claim 1, wherein the ratio of a compound offormula (1) or a mixture of compounds of the formula (I) to a compoundof group (II) is from 625:1 to 1:625.
 8. An active compound combinationaccording to claim 1, wherein the active compound of group (II) areselected from the group consisting of (1) Ergosterol biosynthesisinhibitors, for example aldimorph, azaconazole, bitertanol,bromuconazole, cyproconazole, diclobutrazole, difenoconazole,diniconazole, diniconazole-M, dodemorph, dodemorph acetate,epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamid,fenpropidin, fenpropimorph, fluquiriconazole, flutriafol, furconazole,furconazole-cis, hexaconazole, unazalil, imazalil sulphate,imibenconazole, ipconazole, metconazole, myclobutanil, naftifin,nuarimol, oxpoconazole, paciobutrazole, pefurazoate, penconazole,piperalin, prochioraz, propicanazole, prothioconazole, pyributicarb,pyrifenox, quinconazole, simeconazole, spiroxamine, tebuconazole,terbinafine, tetraconazole, triadimefon, triadimenol, tridemorph,triflumizole, triforine, conazole, uniconazole, uniconazole-p,viniconazole, voriconazole,1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol, methyl1-(2,2-dimethyl-2,3-dihydro-1R-inden-1H-imidazole-5-carboxylate,N′-{5-(difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamide,N-ethyl-N-methyl-N′-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamideandO-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl]1H-imidazole-1-carbothioate,(2) respiration inhibitors (respiratory chain inhibitors), for examplebixafen, boscalid, carboxin, diflumetorim, fenfuram, fluopyram,flutolanil, fluxapyroxad, furametpyr, furmecyclox, isopyrazam mixture ofthe syn-epimeric racemate 1RS,4SR,9RS and of the anti-epimeric racemate1RS,4SR,9SR, isopyrazam (anti-epimeric racemate), isopyrazam(anti-epimeric enantiomer 1RS,4S,9S), isopyrazam (anti-epimericenantiomer 1S,4R,9R), isopyrazam (syn-epimeric racemate 1RS,4SR,9RS),isopyrazam (syn-epimeric enantiomer 1R,4S,9R), isopyrazam (syn-epimericenantiomer 1S,4R,9S), mepronil, oxycarboxin, penflufen, penthiopyrad,sedaxane, thifluzamide,1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-3-(trifluroromethyl)-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-N-[4-fluoro-2-1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-methyl-H-pyrazole-4-carboxamideandN-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,(3) Respiration inhibitors (respiratory chain inhibitors) acting oncomplex III of the respiratory chain, for example ametoctradin,amisulbrom, azoxystrobin, cyazofamid, dimoxystrobin, enestroburin,famoxadorte, fenamidone, fluoxastrobin, kresoxim-methyl,metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin,pyrametostrobin, pyraoxystrobin, pyribencarb, trifloxystrobin,(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,(2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide,(2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide,(2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylethenyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide,(2E)-2-{2-([({[(2E,3E)-4-(2,6-dichlorophenyl)but-3-en-2-ylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide,2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide,5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one,methyl(2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulphanyl)methyl]phenyl}-3-methoxyprop-2-enoate,N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide,2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamideand(2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide,(4) Mitosis and cell division inhibitors, for example benomyl,carbendazim, chlorfenazole, diethofencarb, ethaboxam, fluopicolide,fuberidazole, pencycuron, thiabendazole, thiophanate-methyl,thiophanate, zoxamide,5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidineand3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine,(5) Compounds with multisite activity, for example Bordeaux mixture,captafol, captan, chlorothalonil, copper preparations such as copperhydroxide, copper naphthenate, copper oxide, copper oxychloride, coppersulphate, dichlofluanid, dithianon, dodine, dodine free base, ferbam,fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine,iminoctadine albesilate, iminoctadine triacetate, mancopper, mancozeb,maneb, metiram, metiram zinc, oxine-copper, propamidine, propineb,sulphur and sulphur preparations, for example calcium polysulphide,thiram, tolylfluanid, zineb and ziram, (6) Resistance inductors, forexample acibenzolar-S-methyl, isotianil, probenazole and tiadinil, (7)Amino acid and protein biosynthesis inhibitors, for example andoprim,blasticidin-S, cyprodinil, kasugamycin, kasugamycin hydrochloridehydrate, mepanipyrim and pyrimethanil, (8) ATP production inhibitors,for example fentin acetate, fentin chloride, fentin hydroxide andsilthiofam, (9) Cell wall synthesis inhibitors, for examplebenthiavalicarb, dimethomorph, flumorph, iprovalicarb, mandipropamid,polyoxins, polyoxorim, validamycin A and vaffentilate, (10) Lipid andmembrane synthesis inhibitors, for example biphenyl, chloroneb,dicloran, edifenphos, etridiazole, iodocarb, iprobenfos, isoprothiolane,propamocarb, propamocarb hydrochloride, prothiocarb, pyrazophos,quintozene, tecnazene and tolclofos-methyl, (11) melanin biosynthesisinhibitors, for example carpropamid, diclocymet, fenoxanil, phthalide,pyroquilon and tricyclazole, (12) nucleic acid synthesis inhibitors, forexample benalaxyl, benalaxyl-M (kiralaxyl), bupirimate, clozylacon,dimethirimol, ethirimol, furalaxyl, hymexazol, metalaxyl, metalaxyl-M(mefenoxam), ofurace, oxadixyl, oxolinic acid, (13) signal transductioninhibitors, for example chlozolinate, fenpiclonil, fludioxonil,iprodione, procymidone, quinoxyfen and vinclozolin, (14) Decouplers, forexample binapacryl, dinocap, ferimzone, fluazinam and meptyldinocap.(15) further compounds, for example henthiazole, bethoxazin, capsimycin,carvone, chinomethionat, chlazafenone, cufraneb, cyflufenamid,cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine,difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomat,fenpyrazamine, flumetover, fluoromide, flusulfamide, flutianil,fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene,irumamycin, methasulfocarb, methyl isothiocyanate, metrafenon,mildiomycin, natamycin, nickel dimethyldithiocarbamate,nitrothal-isopropyl, octhilinone, oxamocarb, oxyfenthiin,pentachlorophenol and salts thereof, phenothrin, phosphoric acid andsalts thereof, propamocarb-fosetylate, propanosine-sodium, proquinazid,pyrrolnitrin, tebufloquin, tecloftalam, tolnifanid, triazoxide,trichlamide, zarilamide,1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl 1H-imidazole-1-carboxylate,2,3,5,6-tetrachloro-4-(methylsulphonyl)pyridine,2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,2-[5-methyl-3-(trifluoromethyl)-1Hpyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone, 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one,2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine,2-phenylphenol and salts thereof,3,4,5-trichloropyridine-2,6-dicarbonitrile,3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine,3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine,4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine,5-amino-1,3,4-thiadiazole-2-thiol,5-chloro-N′-phenyl-N′-(prop-2-yn-1-yl)thiophene-2-sulphonohydrazide,5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidine-7-amine,ethyl(2Z)-3-amino-2-cyano-3-phenylprop-2-enoate,N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide,N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,pentyl{6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylidene]amino}oxy)methyl]pyridin-2-yl}carbamate,phenazine-1-carboxylic acid, quinolin-8-ol and quinolin-8-ol sulphate(2:1). (16) further compounds, for example1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole4-carboxamide,N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-(4′-ethynylbiphenyl-2-yl)pyridine-3-carboxamide,2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide,5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanoneandN-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N2-(methylsulphonyl)valinamide.9. An active compound combination according to claim 1, wherein theactive compound of group (II) are selected from the group consisting ofbitertanol bixafen carpropamid fenamidone fluopicolide fluopyramfluoxastrobin fluquinconazole isotianil metominostrobin pencycuronpenflufen prochloraz propamocarb propineb prothioconazole spiroxaminetebuconazole triadimenol triazoxide trifloxystrobin ametoxtradinazoxystrobin benthiavalicarb boscalid carbendazim carboxinchlorothalonil cymoxanil cyproconazole cyprodinil cyazofamiddifenoconazole dimoxystrobin epoxiconazole fenpropidin ferimzonefluazinam fludioxonil flutolanil flutriafol fluxapyroxad gentamycinhymexazol imazalil ipconazole isoprothiolane isopyrazam kasugamycinmanocozeb mandipropamid maneb mefenoxam metalaxyl metconazolemetrafenone orysastrobin penthiopyrad picoxystrobin probenazolepropiconazole proquinazid pyraclostrobin pyrimethanil pyroquilonquinoxyfen sedaxane tetraconazole thiophanate-methyl thiramtolclofos-methyl tricyclazole triticonazole validamycin andfosetyl-aluminium.
 10. Active compound combination according to claim 3,wherein the compound of formula (I-1) are selected from the groupconsisting of the compounds (I-1-1) to (1-1-60).
 11. An Active compoundcombination according to claim 4, wherein the mixture of compound offormula (I-1) are selected from the group consisting of I-1-1-/I-1-7,I-1-2/I-1-8, I-1-3/I-1-9, I-1-4/I-1-10, I-1-5/I-1-11, I-1-5/I-1-12,I-1-13/I-1-1-19, I-1-14/I-1-20, I-1-15/I-1-21, I -1-16/I-1-22,I-1-17/I-1-23, I-1-18/I-1-24, I-1-25/I-1-31, I-1-26/I-1-32,I-1-27/I-1-33, I-1-28/I-1-34, I-1-29/I-1-35, I-1-30/I-1-36,I-1-37/I-1-43, I-1-38/I-1-44, I-1-39/I-1-45, I-1-40/I-1-46,I-1-41/I-1-47, I-1-42/I-1-48, I-1-49/I-1-55, I-1-50/I-1-56,I-1-51/I-1-57, I-1-52/I-1-58, I-1-53/I-1-59, and I-1-54/I-1-60.
 12. Anagrochemical composition comprising an active compound combinationsaccording to claim 1, and also extenders and/or surfactants.
 13. Anactive compound combination according to claim 1 for controlling animalpest, phytopathogenic fungi, or for treating seed.
 14. A method forcontrolling animal pests, comprising allowing the active compoundcombination as defined in claim 1, to act on animal pests and/or theirhabitat.
 15. A process for producing agrochemical compositions, whereinthe active compound combination according to claim 1, are mixed withextenders and/or surfactants.
 16. A method for controlling animal pests,comprising allowing the composition according to claim 12 to act onanimal pests and/or their habitat.
 17. An active compound combinationaccording to claim 12 for controlling animal pest, phytopathogenicfungi, or for treating seed.
 18. Seed treated with an active compoundcombination as define in claim 1.